Bone disorder
MONDO:0005381Diseases of bones.
Also known as: bone element disease, bone element disease or disorder, disease of bone element, disease or disorder of bone element, disorder of bone element, rare bone disease related to a common gene or pathway defect
6290 clinical trials for this condition and its sub-types, 53 tagged with Bone disorder itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Bone disorder
-
Bone inflammation disease 1 trial · 2,667 incl. sub-types
6 sub-types
- Arthritic joint disease 194 trials · 2,548 incl. sub-types Sub-types →
- Epicondylitis 86 trials
- Osteomyelitis 43 trials · 46 incl. sub-types Sub-types →
- Osgood-Schlatter disease 5 trials
- Mastoiditis 1 trial
- Caffey disease 0 trials
-
Bone neoplasm 26 trials · 2,116 incl. sub-types
20 sub-types
- Bone cancer 79 trials · 1,921 incl. sub-types Sub-types →
- Skull neoplasm 0 trials · 161 incl. sub-types Sub-types →
- Bone benign neoplasm 1 trial · 70 incl. sub-types Sub-types →
- Notochordal tumor 0 trials · 34 incl. sub-types Sub-types →
- Ewing sarcoma/peripheral primitive neuroectodermal tumor of bone 0 trials · 7 incl. sub-types Sub-types →
- Solitary bone cyst 6 trials
- Vascular bone neoplasm 0 trials · 4 incl. sub-types Sub-types →
- Ollier disease 3 trials
- Hereditary multiple osteochondromas 3 trials Sub-types →
- Hyperparathyroidism 2 with jaw tumors 1 trial
- Neonatal severe primary hyperparathyroidism 1 trial
- Neoplasm of femur 0 trials · 1 incl. sub-types Sub-types →
- OSLAM syndrome 0 trials
- Aneurysmal bone cyst 0 trials
- Congenital progressive bone marrow failure-B-cell immunodeficiency-skeletal dysplasia syndrome 0 trials
- Diaphyseal medullary stenosis-bone malignancy syndrome 0 trials
- Hyperparathyroidism 1 0 trials
- Hyperparathyroidism 3 0 trials
- Hyperparathyroidism 4 0 trials
- Juvenile hyaline fibromatosis 0 trials
-
Skeletal dysplasia 1 trial · 660 incl. sub-types
119 sub-types
- Osteochondrodysplasia 12 trials · 380 incl. sub-types Sub-types →
- Lysosomal storage disease with skeletal involvement 0 trials · 63 incl. sub-types Sub-types →
- Chondrodysplasia punctata 0 trials · 39 incl. sub-types Sub-types →
- Type 2 collagenopathy 0 trials · 39 incl. sub-types Sub-types →
- Non-syndromic limb reduction defect 0 trials · 35 incl. sub-types Sub-types →
- FGFR3-related chondrodysplasia 0 trials · 33 incl. sub-types Sub-types →
- Abnormal mineralization disorder 0 trials · 22 incl. sub-types Sub-types →
- Syndromic craniosynostosis 1 trial · 22 incl. sub-types Sub-types →
- Osteopetrosis 6 trials · 14 incl. sub-types Sub-types →
- Amniotic band syndrome 8 trials · 9 incl. sub-types Sub-types →
- Primordial dwarfism and slender bone disorder 0 trials · 9 incl. sub-types Sub-types →
- Acromelic dysplasia 0 trials · 8 incl. sub-types Sub-types →
- Polydactyly-syndactyly-triphalangism 0 trials · 6 incl. sub-types Sub-types →
- McCune-Albright syndrome 5 trials
- SHOX-related short stature 5 trials
- Primary osteolysis 0 trials · 5 incl. sub-types Sub-types →
- Filamin-related bone disorder 0 trials · 4 incl. sub-types Sub-types →
- Ollier disease 3 trials
- Proteus syndrome 2 trials
- SLC26A2-related skeletal dysplasia 0 trials · 2 incl. sub-types Sub-types →
- Acheiria 0 trials · 2 incl. sub-types Sub-types →
- Bent bone dysplasia 0 trials · 2 incl. sub-types Sub-types →
- Congenital absence of both forearm and hand 1 trial · 2 incl. sub-types Sub-types →
- Metaphyseal dysplasia-maxillary hypoplasia-brachydacty syndrome 2 trials
- Short rib dysplasia 0 trials · 2 incl. sub-types Sub-types →
- Spondylodysplastic dysplasia 0 trials · 2 incl. sub-types Sub-types →
- 2q37 microdeletion syndrome 1 trial
- COMP-related skeletal dysplasia 0 trials · 1 incl. sub-types Sub-types →
- Currarino triad 1 trial
- Sotos syndrome 1 trial
- Chondromalacia patellae 1 trial
- Coxopodopatellar syndrome 1 trial
- Craniofrontonasal syndrome 1 trial
- Bruck syndrome 0 trials Sub-types →
- Camurati-Engelmann disease 0 trials Sub-types →
- Catel-Manzke syndrome 0 trials
- Cole-Carpenter syndrome 0 trials Sub-types →
- Eiken syndrome 0 trials
- FAM111A-related skeletal dysplasia 0 trials Sub-types →
- Hartsfield-Bixler-Demyer syndrome 0 trials
- LRP5-related primary osteoporosis 0 trials
- Larsen-like osseous dysplasia-short stature syndrome 0 trials
- Larsen-like syndrome, B3GAT3 type 0 trials
- Lenz-Majewski hyperostotic dwarfism 0 trials
- Marshall-Smith syndrome 0 trials
- Richieri Costa-Pereira syndrome 0 trials
- Robinow syndrome 0 trials Sub-types →
- TRIP11-related skeletal dysplasia 0 trials Sub-types →
- TRPV4-related bone disorder 0 trials Sub-types →
- Tatton-Brown-Rahman overgrowth syndrome 0 trials
- Weaver syndrome 0 trials
- Yunis-Varon syndrome 0 trials
- Acrocoxomesomelic dysplasia 0 trials
- Adactyly of foot 0 trials Sub-types →
- Apodia 0 trials Sub-types →
- Autosomal dominant osteosclerosis, Worth type 0 trials
- Autosomal recessive cutis laxa type 2 0 trials Sub-types →
- Baby rattle pelvis dysplasia 0 trials
- Bird headed-dwarfism, Montreal type 0 trials
- Bone dysplasia Moore type 0 trials
- Bone dysplasia corpus callosum agenesis 0 trials
- Brachydactyly-elbow wrist dysplasia syndrome 0 trials
- Calvarial doughnut lesions with bone fragility and spondylometaphyseal dysplasia 0 trials
- Carpotarsal osteochondromatosis 0 trials
- Cerebrocostomandibular syndrome 0 trials
- Chondroectodermal dysplasia with night blindness 0 trials
- Cleidorhizomelic syndrome 0 trials
- Cognitive impairment - coarse facies - heart defects - obesity - pulmonary involvement - short stature - skeletal dysplasia syndrome 0 trials
- Colobomatous microphthalmia-rhizomelic dysplasia syndrome 0 trials
- Complex lethal osteochondrodysplasia 0 trials
- Congenital absence of both lower leg and foot 0 trials Sub-types →
- Congenital absence of thigh and lower leg with foot present 0 trials Sub-types →
- Congenital absence of upper arm and forearm with hand present 0 trials
- Craniometadiaphyseal dysplasia, wormian bone type 0 trials
- Craniotubular dysplasia, Ikegawa type 0 trials
- De la Chapelle dysplasia 0 trials
- Delayed membranous cranial ossification 0 trials
- Diaphyseal medullary stenosis-bone malignancy syndrome 0 trials
- Dyschondrosteosis-nephritis syndrome 0 trials
- Dysplasia epiphysealis hemimelica 0 trials
- Dysplasia of head of femur, Meyer type 0 trials
- Dysspondyloenchondromatosis 0 trials
- Epimetaphyseal skeletal dysplasia 0 trials
- Familial osteodysplasia, Anderson type 0 trials
- Fibular aplasia-ectrodactyly syndrome 0 trials
- Genitopatellar syndrome 0 trials
- Genochondromatosis 0 trials Sub-types →
- Ghosal hematodiaphyseal dysplasia 0 trials
- Hyperostosis corticalis generalisata 0 trials
- Melorheostosis with osteopoikilosis 0 trials
- Mesomelic dwarfism-cleft palate-camptodactyly syndrome 0 trials
- Mesomelic dysplasia-digital anomalies-intellectual disability syndrome 0 trials
- Metaphyseal acroscyphodysplasia 0 trials
- Metaphyseal anadysplasia 0 trials Sub-types →
- Metaphyseal dysostosis-intellectual disability-conductive deafness syndrome 0 trials
- Metaphyseal dysplasia, Braun-Tinschert type 0 trials
- Microcephalic primordial dwarfism due to ZNF335 deficiency 0 trials
- Oculodentodigital dysplasia 0 trials Sub-types →
- Omodysplasia 0 trials Sub-types →
- Osteofibrous dysplasia 0 trials
- Osteoglophonic dysplasia 0 trials
- Pancreatic insufficiency-anemia-hyperostosis syndrome 0 trials
- Parietal foramina 0 trials Sub-types →
- Parietal foramina with cleidocranial dysplasia 0 trials
- Pelvic dysplasia-arthrogryposis of lower limbs syndrome 0 trials
- Proximal femoral focal deficiency 0 trials
- Pseudodiastrophic dysplasia 0 trials
- Rhizomelic dysplasia, Ain-Naz type 0 trials
- Rhizomelic dysplasia, Patterson-Lowry type 0 trials
- Rhizomelic syndrome, Urbach type 0 trials
- Short stature-advanced bone age-early-onset osteoarthritis syndrome 0 trials
- Skeletal dysplasia-epilepsy-short stature syndrome 0 trials
- Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome 0 trials
- Split hand-foot malformation 1 with sensorineural hearing loss 0 trials
- Spondylometaphyseal dysplasia 0 trials Sub-types →
- Synpolydactyly 0 trials Sub-types →
- Tall stature-scoliosis-macrodactyly of the great toes syndrome 0 trials
- Thin ribs-tubular bones-dysmorphism syndrome 0 trials
- Tricho-dento-osseous syndrome 0 trials
-
Bone development disease 2 trials · 527 incl. sub-types
9 sub-types
- Osteochondrodysplasia 12 trials · 380 incl. sub-types Sub-types →
- Dysostosis 0 trials · 85 incl. sub-types Sub-types →
- Developmental dysplasia of the hip 62 trials Sub-types →
- Spondylocarpotarsal synostosis syndrome 2 trials
- Microcephalic osteodysplastic dysplasia, Saul-Wilson type 1 trial
- Angioosteohypotrophic syndrome 0 trials
- Brachydactyly-elbow wrist dysplasia syndrome 0 trials
- Odontoid hypoplasia 0 trials
- Segmental odontomaxillary dysplasia 0 trials
-
Disease of bone structure 1 trial · 456 incl. sub-types
5 sub-types
- Scoliosis 137 trials · 234 incl. sub-types Sub-types →
- Spinal stenosis 120 trials · 154 incl. sub-types Sub-types →
- Spondylolisthesis 77 trials Sub-types →
- Spondylosis 70 trials
- Spondylolysis 6 trials
-
Bone remodeling disease 5 trials · 411 incl. sub-types
6 sub-types
- Bone resorption disease 23 trials · 319 incl. sub-types Sub-types →
- Rickets 10 trials · 41 incl. sub-types Sub-types →
- Hyperostosis 2 trials · 26 incl. sub-types Sub-types →
- Osteosclerosis 1 trial · 16 incl. sub-types Sub-types →
- Fibrous dysplasia 11 trials Sub-types →
- Osteomalacia 2 trials · 4 incl. sub-types Sub-types →
-
Skull disorder 1 trial · 387 incl. sub-types
6 sub-types
- Paranasal sinus disorder 12 trials · 162 incl. sub-types Sub-types →
- Skull neoplasm 0 trials · 161 incl. sub-types Sub-types →
- Disorder of facial skeleton 4 trials · 132 incl. sub-types Sub-types →
- Cochlear disorder 6 trials
- Enlarged vestibular aqueduct syndrome 2 trials
- Petrositis 0 trials
-
Metabolic bone disorder 9 trials · 316 incl. sub-types
4 sub-types
- Osteoporosis 277 trials · 295 incl. sub-types Sub-types →
- Chondrocalcinosis 5 trials · 7 incl. sub-types Sub-types →
- Osteomalacia 2 trials · 4 incl. sub-types Sub-types →
- Bone Paget disease 2 trials Sub-types →
-
Osteonecrosis 59 trials · 224 incl. sub-types
7 sub-types
- Avascular necrosis 80 trials · 141 incl. sub-types Sub-types →
- Osteonecrosis of genetic origin 0 trials · 102 incl. sub-types Sub-types →
- Osteochondrosis 8 trials · 46 incl. sub-types Sub-types →
- Osteoradionecrosis 14 trials · 15 incl. sub-types Sub-types →
- Dieterich disease 1 trial
- Kummell disease 1 trial
- Idiopathic phalangeal acro-osteolysis 0 trials
-
Mucopolysaccharidosis type 3 7 trials · 18 incl. sub-types
4 sub-types
- Mucopolysaccharidosis type 3A 7 trials
- Mucopolysaccharidosis type 3B 6 trials
- Mucopolysaccharidosis type 3C 2 trials
- Mucopolysaccharidosis type 3D 0 trials
-
Mucopolysaccharidosis type 1 11 trials · 16 incl. sub-types
3 sub-types
- Hurler syndrome 6 trials
- Hurler-Scheie syndrome 2 trials
- Scheie syndrome 1 trial
-
Periostitis 0 trials · 16 incl. sub-types
2 sub-types
- Alveolar periostitis 16 trials
- Orbital periostitis 0 trials
-
GM1 gangliosidosis 12 trials
3 sub-types
- GM1 gangliosidosis type 1 3 trials
- GM1 gangliosidosis type 2 3 trials
- GM1 gangliosidosis type 3 0 trials
-
Mucopolysaccharidosis type 9 1 trial
-
ACAN-related short stature spectrum 0 trials · 1 incl. sub-types
-
Baastrup syndrome 0 trials
-
Sagliker syndrome 0 trials
-
Ainhum 0 trials
-
Cervical rib disease 0 trials
-
Coxoauricular syndrome 0 trials
-
Metachondromatosis 0 trials
-
Mueller-weiss syndrome 0 trials
-
Proteoglycan-related bone disorder 0 trials
Most studied deeper sub-types
Showing the 400 most recently updated of 1258 trials in this tab.
-
Can a calming drug make cord blood transplants safer?
Cure PausedResearchers are testing whether adding abatacept to standard immune-suppressing drugs can prevent severe graft-versus-host disease after a double umbilical cord blood transplant. The trial enrolls people with blood cancers such as leukemia, lymphoma, and myelodysplastic syndromes…
Phase 2 • Sponsor: Leland Metheny • Aim: Cure
Last updated Sep 12, 2026 00:00 UTC
-
New cocktail of drugs aimed at halting bone metastases in prostate cancer
Disease control PausedThis study tests a combination of three drugs—radium-223, M3814, and avelumab—in men with advanced prostate cancer that no longer responds to hormone therapy and has spread to the bone. The goal is to see if the combination can slow cancer growth better than radium-223 alone. The…
Phase 1/2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Radioactive Bone-Seeking drug paired with chemo shows promise for advanced breast cancer
Disease control OngoingThis study tests whether adding a radioactive drug (radium-223) to standard chemotherapy (paclitaxel) helps people with advanced breast cancer that has spread to the bones. The radioactive drug targets bone tumors directly, while chemo works throughout the body. About 70 particip…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New antibody takes aim at Hard-to-Treat blood cancers
Disease control OngoingThis early-stage trial tests a new antibody drug called Hu8F4 in 72 people with advanced blood cancers like leukemia and myelodysplastic syndrome. The goal is to find the safest dose and see if it can slow or stop cancer growth. Researchers will also track how long patients live …
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New combo aims to deepen remission in early CML
Disease control OngoingThis study tests whether adding ASTX727 to the standard drug dasatinib can better control chronic myeloid leukemia (CML) in newly diagnosed patients. About 70 adults with a specific genetic marker (Philadelphia chromosome) will receive both pills. The goal is to see if the combin…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New drug duo targets hard-to-treat blood cancers
Disease control OngoingThis study tests a new drug, seclidemstat, combined with a standard drug, azacitidine, for people with myelodysplastic syndromes (MDS) or chronic myelomonocytic leukemia (CMML). The goal is to find the best dose and see if the combination can shrink or control the cancer. About 2…
Phase 1/2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New combo aims to wipe out lingering leukemia before transplant
Disease control OngoingThis phase 2 trial tests whether a combination of venetoclax and azacitidine can clear measurable residual disease (MRD) in adults with acute myeloid leukemia (AML) who still have or develop leftover cancer cells after initial chemotherapy, and before a stem cell transplant. Abou…
Phase 2 • Sponsor: Grupo Cooperativo de Estudio y Tratamiento de las Leucemias Agudas y Mielodisplasias • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New pill hopes to boost blood in bone marrow disease
Disease control OngoingThis study tests an experimental drug, HT-6184, in adults with a bone marrow disorder called myelodysplastic syndrome (MDS) who have low red blood cell counts (anemia). The goal is to see if the drug can improve blood counts and reduce the need for transfusions. Participants take…
Phase 2 • Sponsor: Halia Therapeutics, Inc. • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Cancer drug RVU120 gets extended trial for ongoing patients
Disease control By invitation onlyThis study offers continued RVU120 treatment to up to 10 patients with advanced solid tumors, acute myeloid leukemia, or high-risk myelodysplastic syndrome who are already benefiting from the drug in an earlier trial. The main goal is to monitor safety and see how long patients c…
Phase 2 • Sponsor: Ryvu Therapeutics SA • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Virus plus radiation may shrink sarcomas before surgery
Disease control OngoingThis study tests whether a cancer-killing virus (T-VEC) combined with radiation can shrink soft tissue sarcomas before surgery. About 40 adults with newly diagnosed, removable sarcomas will receive the virus injected into the tumor plus radiation. The main goals are to see how ma…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New hip implant aims to fix cartilage without replacement
Disease control OngoingThis early study is testing a new device called the ReNew Hip Implant in 15 people aged 14 to 64 with hip cartilage damage from conditions like osteoarthritis or hip impingement. The implant is surgically placed to repair the cartilage. Researchers are checking if it is safe and …
Sponsor: Cytex Therapeutics, Inc. • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Experimental drug TAK-243 targets tough blood cancers in early trial
Disease control OngoingThis early-phase study is testing a drug called TAK-243 in people whose acute myeloid leukemia or myelodysplastic syndrome has come back or is not responding to treatment. The goal is to find the best dose and check for side effects. The trial is currently on hold.
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Can an HDAC inhibitor wipe out residual leukemia cells?
Disease control OngoingResearchers are studying whether the drug chidamide can help keep high-risk acute myeloid leukemia (AML) in remission when used as maintenance therapy. The trial enrolls adults with specific genetic features and measurable residual disease who are not receiving a stem cell transp…
Sponsor: Guangdong Second Provincial General Hospital • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
New hope for older leukemia patients with gentler drug combo
Disease control OngoingThis study tests a new two-drug combination (ASTX727 and venetoclax) in adults with acute myeloid leukemia who are 75 or older, or have health issues that make standard strong chemotherapy too risky. The goal is to see if the drugs work well together and can control the leukemia.…
Phase 1/2 • Sponsor: Taiho Oncology, Inc. • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Could a natural compound in food help beat knee implant infections?
Disease control PausedThis trial tests whether a dietary supplement called protocatechuic acid (PCA) can improve health markers in people undergoing revision surgery for a knee prosthetic joint infection. Participants take PCA before and after surgery, and researchers measure changes in immune and met…
Sponsor: Dr. Dean Reeves Clinic • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
New hope for Hard-to-Treat leukemia: targeted pill combined with chemotherapy enters human trials
Disease control OngoingThis early-stage trial is testing a new oral drug called SNDX-5613 alongside standard intensive chemotherapy in people newly diagnosed with acute myeloid leukemia (AML) that has specific genetic changes (KMT2A, NPM1, or NUP98). The study aims to see if the combination is safe and…
Phase 1 • Sponsor: Syndax Pharmaceuticals • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Could a quick insulin shot stop Steroid-Induced blood sugar spikes?
Disease control OngoingSteroid injections for knee arthritis can temporarily raise blood sugar in people with type 2 diabetes. This trial tests whether giving a short course of NPH insulin right after the injection can prevent those high blood sugar episodes. Adults with type 2 diabetes and knee osteoa…
Phase 1/2 • Sponsor: Shifa International Hospital • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Immunotherapy boost may wipe out stubborn leukemia cells
Disease control OngoingThis study tests whether adding the immunotherapy drug pembrolizumab to standard tyrosine kinase inhibitors (TKIs) can eliminate tiny amounts of leftover leukemia cells in people with chronic myeloid leukemia (CML). About 40 adults with CML who still have detectable cancer marker…
Phase 2 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Engineered donor cells aim to beat blood cancer without severe side effects
Disease control OngoingThis study tests a new way to treat children and young adults with high-risk blood cancers like leukemia and lymphoma. Doctors take blood cells from a family donor, remove certain T cells that can cause a harmful immune reaction, and then transplant the modified cells. The goal i…
Phase 2 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Immunotherapy combo shows promise against rare sarcomas before surgery
Disease control OngoingThis study tests whether giving immunotherapy drugs (nivolumab with or without ipilimumab) and radiation before surgery can help shrink tumors in people with two rare types of sarcoma. About 32 adults with these cancers that can be surgically removed will receive the treatment an…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
New drug combo shows promise in controlling Early-Stage leukemia
Disease control OngoingThis study tests a combination of two drugs, dasatinib and venetoclax, in people with early chronic phase chronic myeloid leukemia (CML). The goal is to see if the combination can better control the disease by blocking enzymes that help cancer cells grow. About 155 participants w…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
Could a daily ultrasound zap arthritis pain at home?
Disease control OngoingThis study tests a non-invasive device that uses ultrasound to stimulate the spleen and reduce inflammation in people with moderate to severe rheumatoid arthritis. About 60 adults who haven't responded well to standard medications will use the device at home for 12 weeks, with so…
Sponsor: SecondWave Systems Inc. • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
New drug cocktail aims to stop leukemia relapse after transplant
Disease control OngoingThis phase 2 trial tests whether combining venetoclax and azacitidine after a stem cell transplant can prevent leukemia from returning in high-risk patients. About 100 adults aged 18-75 with certain types of acute leukemia who are in remission after transplant will receive the dr…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
Can simple yoga poses straighten curved spines in children?
Disease control OngoingResearchers are testing whether a short daily routine of one or two yoga poses can reduce spinal curvature in children aged 8 to 12 with juvenile idiopathic lumbar scoliosis. Participants practice the poses for 5 to 7 minutes, three times a day, for four months. Some children sta…
Sponsor: Manhattan Physical Medicine and Rehabilitation, LLP • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
Experimental CART123 therapy targets tough blood cancers in early trial
Disease control OngoingThis early-phase trial tests a personalized cell therapy called CART123 for people with certain blood cancers (like AML or MDS) that have not responded to standard treatments. Each patient's own immune cells are modified in a lab to recognize and attack cancer cells. The main goa…
Early phase 1 • Sponsor: Institute of Hematology and Blood Transfusion, Czech Republic • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
Dialysis upgrade could protect bones in kidney patients
Disease control OngoingThis study tests whether a newer type of dialysis filter (medium cut-off membrane) can better manage bone and mineral problems common in people with end-stage kidney disease. Thirty adults on maintenance dialysis will try both the new and standard filters for three months each. R…
Sponsor: Gazi University • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
Can a Patient's own blood beat a standard dressing for dry socket?
Disease control OngoingThis trial tests two treatments for dry socket, a painful complication after tooth extraction. One is Alvogyl, a standard medicated dressing. The other is platelet-rich fibrin (PRF), made from the patient's own blood, which may help tissue heal. About 102 adults with dry socket w…
Sponsor: CMH Lahore Medical College and Institute of Dentistry • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
Blood cancer combo trial pulled before it even started
Disease control CancelledThis study was designed to test whether adding olutasidenib to standard chemotherapy drugs could help control certain blood cancers in people with an IDH1 gene mutation. The trial was withdrawn before enrolling any participants, so no results are available.
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
New bone graft material could improve spine surgery outcomes
Disease control OngoingThis study is testing a material called Orthoss®, made from granules, to help bones in the spine fuse together after surgery. The trial includes 65 adults with lower back problems like slipped discs or narrowing of the spine canal. Doctors will check if the bones fuse properly an…
Sponsor: Geistlich Pharma AG • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
Can an oral drug calm psoriatic arthritis? phase 3 trial puts deucravacitinib to the test
Disease control OngoingResearchers are testing whether deucravacitinib, a daily oral drug, can reduce joint swelling, tenderness, and skin symptoms in people with active psoriatic arthritis. The trial enrolls adults who have not taken biologic drugs for their arthritis or who previously received a TNF …
Phase 3 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
New cocktail of cancer drugs tested for tough leukemia
Disease control OngoingThis early-phase trial tests a combination of three drugs — bortezomib, sorafenib, and decitabine — in patients with acute myeloid leukemia (AML), especially those who are older or have hard-to-treat forms. The main goal is to find the safest dose and see how well patients tolera…
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
New triple therapy targets FLT3-Mutated leukemia in frail patients
Disease control OngoingThis study tests a combination of three drugs—gilteritinib, venetoclax, and azacitidine—in people newly diagnosed with a fast-growing form of acute myeloid leukemia (AML) that has a FLT3 gene change. Participants are older or have other health issues that prevent them from receiv…
Phase 1/2 • Sponsor: Astellas Pharma Global Development, Inc. • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
New drug DFV890 takes on Hard-to-Treat blood cancers
Disease control OngoingThis early-stage trial tests a new drug called DFV890 in about 62 adults with low-risk myelodysplastic syndromes, low-risk chronic myelomonocytic leukemia, or high-risk clonal cytopenia of undetermined significance. The main goals are to check the drug's safety, find the best dos…
Phase 1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Can a new drug trio overcome venetoclax resistance in leukemia?
Disease control By invitation onlyResearchers are testing whether a combination of homoharringtonine, lisaftoclax, and azacitidine can help adults with acute myeloid leukemia (AML) whose disease stopped responding to venetoclax-based treatment. The trial plans to enroll 73 participants and give them the three dru…
Phase 2 • Sponsor: Guangdong Second Provincial General Hospital • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Could a cancer drug help patients with rare gene changes?
Disease control OngoingThis phase 2 trial tests the drug olaparib in 14 adults with acute myeloid leukemia or myelodysplastic syndrome that has returned or not responded to treatment, and whose cancer has a specific change in the IDH gene. Olaparib is a pill that may block enzymes cancer cells need to …
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
New cell therapy aims to stop blood cancer relapse in tough-to-treat patients
Disease control CancelledThis early-phase study tests a new cell therapy called BSB-2002 in adults with a specific type of acute myeloid leukemia (AML) that has returned or not responded to at least two prior treatments. The main goals are to check safety and see if it can prevent the cancer from coming …
Phase 1 • Sponsor: BlueSphere Bio, Inc • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Could dead donors provide Life-Saving bone marrow?
Disease control OngoingThis early study is testing whether bone marrow from deceased donors can be safely used for transplants in people with blood cancers like leukemia and lymphoma. Twelve patients will receive the transplant along with chemotherapy or radiation. The main goal is to see if the new ma…
Phase 1/2 • Sponsor: Ossium Health, Inc. • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
New hope for rare leukemia: Anthracycline-Free combo trial launches
Disease control OngoingThis study tests a combination of drugs (venetoclax plus azacitidine, decitabine, or cytarabine) without traditional anthracycline chemotherapy in 40 adults newly diagnosed with a specific genetic subtype of acute myeloid leukemia (CBFβ::MYH11-positive). The goal is to see if thi…
Phase 2 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
New arthritis drug shows promise in Long-Term safety trial
Disease control By invitation onlyThis study looks at the long-term safety and effectiveness of a drug called sonelokimab for people with psoriatic arthritis. About 1560 adults who finished an earlier study will receive the drug as a shot under the skin. Researchers will track side effects and how well the drug c…
Phase 3 • Sponsor: MoonLake Immunotherapeutics AG • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Experimental combo aims to outsmart relapsed blood cancers
Disease control OngoingThis early-stage trial tests whether adding the immunotherapy drug ipilimumab to the chemotherapy drug decitabine is safe and tolerable for people with myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML) that has come back or stopped responding to treatment. About 54 p…
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Daily Bone-Growth drug tested for taller stature in hypochondroplasia
Disease control By invitation onlyResearchers are studying whether daily injections of vosoritide can safely improve long-term growth in children with hypochondroplasia, a genetic condition that causes short stature. The trial enrolls about 140 children who have already taken vosoritide in earlier studies and who…
Phase 3 • Sponsor: BioMarin Pharmaceutical • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
New enzyme therapy aims to reach the brain in MPS II
Disease control OngoingResearchers are testing tividenofusp alfa (DNL310), an experimental enzyme replacement therapy, against the standard treatment idursulfase in children and young adults with mucopolysaccharidosis type II (MPS II). The study includes participants with and without brain involvement,…
Phase 2/3 • Sponsor: Denali Therapeutics Inc. • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Can adding another drug improve MDS treatment?
Disease control OngoingThis study compares the standard drug azacitidine alone versus azacitidine combined with either lenalidomide or vorinostat in 282 patients with higher-risk myelodysplastic syndromes (MDS) or chronic myelomonocytic leukemia (CMML). The goal is to see if any combination improves re…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
New pill combo aims to tame bone marrow cancer
Disease control OngoingThis early-phase study tests whether adding a new drug called pelabresib to the standard treatment ruxolitinib is safe and helpful for Japanese adults with myelofibrosis, a type of bone marrow cancer. Only 6 people will take part, and the main goal is to check for side effects an…
Phase 1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
New drug combo targets tough blood cancers in early trial
Disease control OngoingThis early-phase study tests a new drug called SEA-CD70, alone or with standard drugs azacitidine and venetoclax, in people with myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML). The main goal is to check safety and find the right dose. About 178 participants will b…
Phase 1 • Sponsor: Seagen, a wholly owned subsidiary of Pfizer • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Can a new enzyme therapy tame MPS II over time?
Disease control OngoingThis study tests the long-term safety and effects of JR-141, an enzyme replacement therapy, in people with mucopolysaccharidosis II (MPS II), a rare genetic disorder. Participants who completed an earlier JR-141 trial receive the drug again by IV infusion. Researchers track side …
Phase 2 • Sponsor: JCR Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
New gene shot could regrow knee cartilage and ease arthritis pain
Disease control CancelledThis early-phase study tests a single injection of ICM-203, a gene therapy that delivers a gene to promote cartilage growth and reduce inflammation in the knee. About 18 adults with mild to moderate knee osteoarthritis will receive escalating doses to check safety and whether it …
Phase 1/2 • Sponsor: ICM Co. Ltd. • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Can a direct brain infusion slow sanfilippo syndrome?
Disease control OngoingThis trial tests an experimental enzyme replacement called GC1130A in children with Sanfilippo syndrome type A, a rare genetic disease that damages the brain. The enzyme is given through a small device placed under the scalp that delivers it directly into the fluid around the bra…
Phase 1 • Sponsor: GC Biopharma Corp • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Could a targeted drug boost chemo for osteosarcoma?
Disease control PausedThis trial is testing whether adding the targeted drug cabozantinib to standard chemotherapy (methotrexate, doxorubicin, and cisplatin) helps people with newly diagnosed osteosarcoma, a type of bone cancer. The study includes over 1,100 participants and aims to see if the combina…
Phase 2/3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Can a weekly infusion reach the brain to fight a rare childhood disease?
Disease control OngoingThis trial tests an experimental drug called JR-441 in children with mucopolysaccharidosis type IIIA (MPS IIIA), a rare genetic condition that harms the brain and body. Researchers give the drug as a weekly intravenous infusion to see if it is safe and tolerable. They also measur…
Phase 1/2 • Sponsor: JCR Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Promising drug cocktail targets tough blood cancers
Disease control OngoingThis study tests a combination of two drugs, venetoclax and ASTX727, in people with high-risk myelodysplastic syndrome (MDS) or chronic myelomonocytic leukemia (CMML) who haven't had treatment before. The goal is to find the safest dose and see if the combo can shrink or control …
Phase 1/2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Can a tiny metal plug fix painful ankle defects?
Disease control OngoingThis trial tests whether a small metal implant, called the Episealer Talus, can relieve pain and improve function in people with a specific type of ankle cartilage damage. The study will enroll 20 adults aged 18 to 65 who have a focal defect on the talus bone and have not improve…
Sponsor: Stefano Zaffagnini • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Can a targeted drug hit the mark in Hard-to-Treat blood cancers?
Disease control OngoingThis trial tests an experimental drug called IMGN632 in people with certain blood cancers, including acute myeloid leukemia and blastic plasmacytoid dendritic cell neoplasm. The drug is designed to find and attack cancer cells that carry a protein called CD123 on their surface. R…
Phase 1/2 • Sponsor: AbbVie • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Targeted drug shows promise for rare bone cancer
Disease control OngoingThis phase 2 trial is testing whether cetuximab, a targeted antibody drug, can shrink tumors in people with advanced or metastatic chordoma, a rare type of bone cancer. About 29 adults with inoperable or spread chordoma will receive cetuximab intravenously. The main goal is to se…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Immune cell reprogramming offers hope for stubborn arthritis and Sjogren's
Disease control OngoingThis early-phase study tests a personalized cell therapy (rapcabtagene autoleucel) in 27 adults with difficult-to-treat rheumatoid arthritis or severe Sjogren's disease. The treatment uses a patient's own immune cells, modified to target and calm the overactive immune system. The…
Phase 1/2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
New drug combo offers hope for older AML patients who Can't tolerate chemo
Disease control OngoingThis study tests whether combining venetoclax with ASTX727 can help control acute myeloid leukemia (AML) in two groups: patients whose cancer returned or didn't respond to prior treatment, and older adults newly diagnosed who cannot handle strong chemotherapy. The drugs work toge…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Can a Two-Drug combo in one liposome beat AML at first try?
Disease control OngoingThis pilot trial tests whether Vyxeos, a liposomal formulation combining two chemotherapy drugs, can effectively treat newly diagnosed low- or intermediate-risk acute myeloid leukemia (AML) in adults aged 18 to 70. Some participants also receive Mylotarg, an antibody-drug conjuga…
Phase 2 • Sponsor: Shaare Zedek Medical Center • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New drug GS-0151 tested for rheumatoid arthritis in early trial
Disease control OngoingThis early-stage trial is testing a new drug called GS-0151 in 75 adults with rheumatoid arthritis. The main goal is to see if the drug is safe and how the body processes it. Participants will receive either GS-0151 or a placebo for 12 weeks.
Phase 1 • Sponsor: Gilead Sciences • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Could removing certain immune cells prevent a deadly transplant complication?
Disease control OngoingThis study tests whether removing a specific type of immune cell (naive T cells) from donor stem cells can prevent chronic graft-versus-host disease (GVHD) in children and young adults with blood cancers. GVHD occurs when donor cells attack the patient's body after a stem cell tr…
Phase 2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Can a lower dose of a leukemia drug keep the disease in check?
Disease control OngoingThis study tests whether reducing the dose of the cancer drug radotinib can still control chronic myeloid leukemia in its early phase while possibly easing side effects. Adults newly diagnosed with this blood cancer take a lower dose twice daily for up to a year. Researchers meas…
Sponsor: Il-Yang Pharm. Co., Ltd. • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Can a newer drug outperform the standard for chronic myeloid leukemia?
Disease control OngoingThis phase III trial compares two oral drugs, radotinib and imatinib, in adults newly diagnosed with chronic myeloid leukemia in its chronic phase. Researchers want to see if radotinib, taken twice daily, achieves a deeper molecular response at 12 months than imatinib, taken once…
Phase 3 • Sponsor: Il-Yang Pharm. Co., Ltd. • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New drug CND261 tested for rheumatoid arthritis relief
Disease control OngoingThis early-stage study tests a new drug, CND261, in 47 adults with moderate to severe rheumatoid arthritis who haven't responded well to other treatments. The main goal is to check the drug's safety and how the body processes it. Researchers will also look for signs that it might…
Phase 1 • Sponsor: Candid Therapeutics • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Can a new knee implant design offer better Long-Term relief?
Disease control By invitation onlyThis study tests a new total knee replacement system called LinkSymphoKnee, which uses an ultra-congruent bearing surface designed to provide stability and mimic natural knee movement. Researchers will enroll 600 adults aged 18 to 79 who need a knee replacement due to osteoarthri…
Sponsor: LinkBio Corp. • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Can a weekly infusion slow the toll of a rare genetic disease?
Disease control OngoingThis trial tests whether JR-141, an enzyme replacement therapy given as a weekly IV infusion, can safely manage mucopolysaccharidosis type II (MPS II) over the long term. Researchers will follow about 27 people who completed an earlier JR-141 study, tracking side effects, develop…
Phase 2/3 • Sponsor: JCR Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Gene therapy for knee pain: does it last?
Disease control OngoingThis study follows 16 people who previously received ICM-203 (a gene therapy) or a placebo for knee osteoarthritis. Researchers will track delayed side effects and measure changes in knee pain and function over time. The goal is to understand the long-term safety and effectivenes…
Sponsor: ICM Co. Ltd. • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New Bone-Boosting shot tested for first time in humans
Disease control OngoingThis early-stage study tests a new injectable drug called LYN101 in 44 people. First, healthy volunteers get a single dose to check safety. Then, postmenopausal women with low bone mass get multiple doses to see how the drug affects bone turnover markers. The main goal is safety,…
Phase 1 • Sponsor: Shanghai TTM-Bio Technology Co., Ltd • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Can a drug combo boost red blood cells in bone marrow disease?
Disease control OngoingThis phase 3 trial compares two treatments for people with a bone marrow disorder called myelodysplastic syndrome (MDS) who have low red blood cell counts (anemia). One group gets lenalidomide alone, the other gets lenalidomide plus epoetin alfa, a drug that stimulates red blood …
Phase 3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Old asthma drug shows promise for rare genetic disorder
Disease control OngoingThis phase 2 trial tests whether theophylline, a drug used for asthma, can help people with pseudohypoparathyroidism lose weight and improve blood sugar control. The study includes 29 obese participants aged 13 and older. Researchers will measure changes in body mass index and gl…
Phase 2 • Sponsor: Vanderbilt University Medical Center • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Can an enzyme blocker boost leukemia chemotherapy?
Disease control OngoingThis phase 1 trial tests whether adding the experimental drug calaspargase pegol-mknl to standard chemotherapy can safely help adults with newly diagnosed acute myeloid leukemia (AML). Researchers aim to find the highest tolerable dose and watch for side effects. They will also t…
Phase 1 • Sponsor: West Virginia University • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Can navigation make hip replacements more precise?
Disease control OngoingThis trial tests whether using a navigation system during hip replacement surgery leads to more accurate joint reconstruction than the traditional measured technique. Researchers will compare the surgeon's pre-operative 3-D plan with the actual post-operative result in 100 patien…
Sponsor: Ottawa Hospital Research Institute • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Could a common asthma drug help treat a rare genetic disorder?
Disease control By invitation onlyThis study tests whether theophylline, a drug used for asthma, can help children and young adults with pseudohypoparathyroidism—a rare genetic condition causing early obesity, hormone problems, and short stature. Researchers will check for weight loss, better blood sugar control,…
Phase 2 • Sponsor: Jaclyn Tamaroff • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New hip implant aims to cut repeat surgeries
Disease control OngoingThis study is testing a new hip implant called the OR3O Dual Mobility System in 177 people who need hip replacement surgery. The goal is to see if the implant is safe and lasts longer without needing another surgery. Researchers will follow participants for up to 10 years to chec…
Sponsor: Smith & Nephew, Inc. • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Precision radiation may make stem cell transplants safer for leukemia patients
Disease control OngoingThis study tests a new way to deliver radiation before a stem cell transplant for people with leukemia or myelodysplastic syndrome. Instead of radiating the whole body, the new method targets only the bone marrow and lymph nodes, which may reduce damage to healthy organs. The goa…
Phase 2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
New hope for rare blood disorder: drug targets overactive immune cells
Disease control OngoingThis phase 2 trial is testing the drug ruxolitinib in people with hypereosinophilic syndrome, a rare condition where the body produces too many eosinophils (a type of white blood cell), causing organ damage. The study aims to see if ruxolitinib can normalize blood cell counts and…
Phase 2 • Sponsor: Stanford University • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Can Blood-Based injections realign the jaw joint?
Disease control OngoingThis trial compares two injection treatments for a common jaw joint problem where the disc slips out of place but returns, causing pain and clicking. One treatment uses a concentrate from the patient's own blood, called platelet-rich fibrin, while the other uses a sugar solution.…
Phase 2 • Sponsor: Cairo University • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
New combo therapy shows promise for tough kidney cancer
Disease control OngoingThis study tests whether adding the targeted therapy cabozantinib to standard immunotherapy (nivolumab and ipilimumab) helps people with advanced kidney cancer live longer. About 1,175 adults with kidney cancer that has spread will receive either the usual treatment or the usual …
Phase 3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
New biologic shot aims to stop psoriatic arthritis joint damage
Disease control OngoingThis phase 3 trial tested guselkumab, a biologic drug given as a shot, in over 1,000 people with active psoriatic arthritis who had not responded well to other treatments. The goal was to see if it reduces symptoms like joint pain and swelling and slows joint damage seen on X-ray…
Phase 3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
New shoulder implant tested for long-term relief in severe tears and arthritis
Disease control OngoingThis study follows 200 adults who receive the Shoulder iD™ implant to treat severe rotator cuff tears or shoulder arthritis. Researchers measure how well the shoulder works and how often the implant needs to be fixed or replaced over 10 years. Participants attend regular check-up…
Sponsor: Stryker Trauma and Extremities • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Can a diet calm inflamed joints in children with arthritis?
Disease control OngoingResearchers are testing whether a specific carbohydrate diet, which has anti-inflammatory effects in children with inflammatory bowel disease, can also reduce joint inflammation in children with juvenile idiopathic arthritis. The trial includes children up to age 16 with low to m…
Sponsor: Uppsala University • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Can a new drug overcome a tough leukemia mutation?
Disease control OngoingThis trial tests whether asciminib, a drug taken twice daily, can reduce leukemia burden in people with chronic phase chronic myeloid leukemia (CML) who have a specific T315I mutation. The study enrolls 50 adults in Germany, including those who had a stem cell transplant. The mai…
Phase 2 • Sponsor: Thomas Ernst, PD Dr. med. • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
Can augmented reality make spinal screws safer?
Disease control OngoingThis trial compares two computer-assisted navigation methods with the traditional free-hand technique for placing pedicle screws during spinal deformity surgery. The goal is to see which approach places screws most accurately, using a CT scan during the operation to check. The st…
Sponsor: Karolinska Institutet • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
Can a new drug regimen beat the standard for stem cell transplant complications?
Disease control OngoingThis trial tests whether a drug called cyclophosphamide (PTCY) can prevent graft-versus-host disease (GVHD) better than the current standard, ATG, in patients receiving stem cell transplants from unrelated donors. GVHD is a serious complication where donor immune cells attack the…
Phase 3 • Sponsor: DKMS gemeinnützige GmbH • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
Can a Night-Time brace or targeted exercises halt scoliosis curves in teens?
Disease control OngoingThis trial tests three conservative approaches for adolescents with idiopathic scoliosis, a spine curvature that develops in childhood. Researchers compare a hypercorrective night-time brace worn for 8 hours, scoliosis-specific exercises, and general physical activity to see whic…
Sponsor: Karolinska Institutet • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
Could a single bone screw save ankles from arthritis?
Disease control OngoingThis trial compares two surgical approaches for a common type of ankle fracture. Half of the participants will have the posterior bone fragment fixed with a plate or screw, while the other half will not. The goal is to see if fixing this fragment makes the ankle joint stable enou…
Sponsor: Groupe Hospitalier Diaconesses Croix Saint-Simon • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
New ankle implant tracked for 10 years in arthritis patients
Disease control OngoingThis study follows 200 adults with ankle arthritis who received the INFINITY ankle replacement. Researchers will check how long the implant lasts and monitor for any problems like loosening or cysts over 10 years. The goal is to see if this device works as well as other similar i…
Sponsor: Stryker Trauma and Extremities • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
Can telemedicine bring IV antibiotics home?
Disease control OngoingThis trial tests a new model where patients with infections receive intravenous antibiotics at home instead of staying in the hospital. Nurses from a municipal response team visit the patient, while hospital doctors oversee the treatment remotely using telemedicine and welfare te…
Sponsor: Helse Møre og Romsdal HF • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
Can a Two-Drug attack outsmart resistant leukemia?
Disease control OngoingThis early-stage trial is testing whether adding an experimental drug called iadademstat to the approved leukemia drug gilteritinib can help people with a specific type of acute myeloid leukemia (AML) that has returned or not responded to treatment. The study focuses on patients …
Phase 1 • Sponsor: Oryzon Genomics S.A. • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
New radiation drug shows promise for Tough-to-Treat breast cancer
Disease control OngoingThis early-phase trial tests a drug called RYZ101 in people with a specific type of advanced breast cancer (ER+, HER2-) that has not responded to standard treatments. The drug delivers radiation directly to cancer cells that have a certain marker (SSTR). The goal is to see if it …
Phase 1/2 • Sponsor: RayzeBio, Inc. • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
Surgery or strength? new study pits hip replacement against exercise for arthritis pain
Disease control OngoingThis study compares two treatments for end-stage hip osteoarthritis: total hip replacement surgery and progressive resistance training (strength exercises). About 109 adults aged 50 and older with severe hip arthritis will be randomly assigned to one of the two treatments. The ma…
Sponsor: Vejle Hospital • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
Can a drug duo keep High-Risk blood cancers at bay after transplant?
Disease control OngoingThis early-phase trial is exploring whether combining two drugs, selinexor and azacitidine, can help prevent relapse in people with high-risk acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) who carry a TP53 mutation and have already undergone a stem cell transplant…
Phase 1/2 • Sponsor: Liping Dou • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
Could a personalized diet tame rheumatoid arthritis and protect the heart?
Disease control By invitation onlyThis study tests whether a personalized diet, based on the latest Nordic Nutrition Recommendations, can reduce disease activity and cardiovascular risk in people newly diagnosed with rheumatoid arthritis. About 150 participants will be randomly assigned to either a diet following…
Sponsor: Vastra Gotaland Region • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
Can a new drug combo push CML into deep remission?
Disease control OngoingThis phase 2 trial is testing whether adding the experimental drug asciminib to standard treatments (imatinib, nilotinib, or dasatinib) can achieve deeper molecular responses in adults newly diagnosed with chronic-phase chronic myeloid leukemia (CML). Participants receive one of …
Phase 2 • Sponsor: University of Jena • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
Lower drug dose after transplant may cut infections without losing protection
Disease control OngoingThis study tests whether a lower dose of the drug cyclophosphamide, given after a stem cell transplant from a partially matched donor, can reduce serious infections in the first 100 days while still preventing graft-versus-host disease (a common complication where donor cells att…
Phase 2 • Sponsor: Center for International Blood and Marrow Transplant Research • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
Which knee implant stays put longer? a Head-to-Head test
Disease control OngoingThis trial aims to see if there is a difference in how well two cementless total knee replacement implants hold up over time. About 50 people with knee osteoarthritis will be randomly assigned to receive either the Triathlon Tritanium or the GMK Sphere implant. Using CT scans, re…
Sponsor: Helse Møre og Romsdal HF • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
New combo therapy targets high-risk MDS in early trial
Disease control CancelledThis study tests a new two-drug combination (pacritinib plus azacitidine) for people with moderate to very high risk myelodysplastic syndrome (MDS), a bone marrow disorder. The first part finds the safest dose of pacritinib, and the second part checks how well the combination wor…
Phase 1/2 • Sponsor: Thomas Jefferson University • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
Weekly shot may help short kids grow – new study underway
Disease control OngoingThis study tests a new growth hormone medicine called somapacitan, given once a week, in 47 children who are very short due to being born small for gestational age, or having Turner syndrome, Noonan syndrome, or idiopathic short stature. The main goal is to see if it is safe and …
Phase 3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Can a targeted drug outperform standard care for rare blood cancers?
Disease control OngoingThis trial compares the drug ruxolitinib against the best available standard treatments for people with high-risk polycythemia vera (PV) or essential thrombocythemia (ET), two rare blood cancers that cause overproduction of blood cells and can lead to clots, bleeding, and severe …
Phase 2 • Sponsor: RWTH Aachen University • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Ceramic hip resurfacing: a Metal-Free future for joint replacement?
Disease control OngoingThis study is testing a new type of hip resurfacing device made entirely of ceramic, designed for people with hip osteoarthritis, necrosis, or dysplasia. The goal is to see if it is as safe and effective as existing metal-on-metal devices, but without releasing metal ions into th…
Sponsor: Embody Orthopaedic Limited • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Which knee implant feels more natural? a trial puts two designs to the test
Disease control OngoingThis trial compares two types of knee replacement implants: one that keeps the posterior cruciate ligament (CR) and one that does not (PS). Both are implanted using a computer-assisted personalized technique that aims to restore the knee's natural alignment. The study includes 14…
Sponsor: Groupe Hospitalier Diaconesses Croix Saint-Simon • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
New hope for babies with rare calcification disease: first drug trial launches
Disease control OngoingThis study tests a new drug called INZ-701 in up to 16 infants (up to 1 year old) with rare genetic conditions (ENPP1 or ABCC6 deficiency) that cause dangerous calcium buildup in arteries and other problems. The main goal is to check the drug's safety and how the body handles it,…
Phase 1 • Sponsor: Inozyme Pharma • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Ear cartilage to the rescue? a tiny biopsy could rebuild knees
Disease control OngoingThis trial is testing whether a single injection of micrografts made from a patient's own ear cartilage can improve symptoms and knee function in adults with moderate knee osteoarthritis. The micrografts are prepared from a small ear cartilage sample using a special device, witho…
Sponsor: Regenera Activa Worldwide S.L. • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Can a pill target Hard-to-Treat bile duct cancers? a new drug puts FGFR2 mutations to the test
Disease control OngoingThis early-stage trial is testing an experimental oral drug, TYRA-200, in people with advanced bile duct cancer (intrahepatic cholangiocarcinoma) and other solid tumors that have specific changes in the FGFR2 gene. The study aims to find a safe and effective dose and to see wheth…
Phase 1 • Sponsor: Tyra Biosciences, Inc • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Could pelvic floor training straighten scoliosis curves?
Disease control OngoingThis trial tests whether adding pelvic floor muscle training to standard scoliosis-specific exercises can better reduce spine curvature in adolescents with idiopathic scoliosis. Participants aged 10-18 with mild to moderate curves will be randomly assigned to either exercises alo…
Sponsor: Gazi University • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
Could exercise replace the scalpel for shoulder arthritis?
Disease control By invitation onlyThis trial tests whether a 12-week program of physical therapy or home exercises can reduce pain and improve shoulder function in adults with glenohumeral arthritis, compared with no treatment. Participants are randomly assigned to one of three groups: supervised physical therapy…
Sponsor: State University of New York at Buffalo • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
Can a new pill ease arthritis in kids?
Disease control OngoingThis study is testing an oral medication called upadacitinib in children with polyarticular juvenile idiopathic arthritis (JIA), a condition causing joint inflammation. The goal is to understand how the drug moves through the body, its safety, and how well children tolerate it. P…
Phase 1 • Sponsor: AbbVie • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Can a new drug reduce bloodletting for polycythemia vera?
Disease control CancelledThis trial investigates whether ropeginterferon alfa-2b can help people with polycythemia vera, a condition where the body makes too many red blood cells. The study will compare the drug to standard care, which includes phlebotomy (removing blood) and aspirin. About 70 adults wit…
Phase 4 • Sponsor: PharmaEssentia • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Targeted exercise may straighten spines in teens with scoliosis — a trial puts it to the test
Disease control By invitation onlyThis trial tests whether a structured 16-week corrective exercise program can improve spinal alignment in adolescents aged 10–18 with mild to moderate scoliosis (Cobb angle 10°–40°). Participants are randomly assigned to either the corrective program or standard physiotherapy. Th…
Sponsor: Alma Mater Europaea - Slovenia • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
New drug could shrink rare joint tumors without surgery
Disease control OngoingThis study tests an investigational drug called emactuzumab for people with a rare joint tumor (TGCT) that can't be removed surgically. About 128 participants will receive either the drug or a placebo to see if it shrinks tumors and improves joint function. The goal is to offer a…
Phase 3 • Sponsor: SynOx Therapeutics Limited • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
Radioactive therapy targets stubborn leukemia in early trial
Disease control OngoingThis study tests a new radioactive drug called [177Lu]Lu-PentixaTher in people with acute leukemia that has come back or not responded to standard treatments. The drug seeks out and delivers radiation directly to leukemia cells that have a specific marker (CXCR4). The main goals …
Phase 1/2 • Sponsor: Nantes University Hospital • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
Can a single surgery fix ankle cartilage for a decade? a long-term study puts AMIC to the test.
Disease control OngoingThis study looks at how well a surgical technique called AMIC holds up ten years after repairing cartilage damage in the ankle. Researchers are checking whether the pain relief and function patients gained in the first few years remain stable or fade over time. About 40 people wh…
Sponsor: I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Can an oxygen gel heal medication-damaged jaw bone better than a blood-derived patch?
Disease control OngoingThis trial compares two treatments applied during surgery to help heal jaw bone damage caused by bisphosphonates or similar drugs. One is an oxygen-based gel, the other is a membrane made from the patient's own platelets. Researchers will measure how completely the bone and soft …
Sponsor: Mansoura University • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Can a single infusion lock in bone gains after osteoporosis treatment?
Disease control OngoingThis trial investigates whether a single or repeat infusion of zoledronate, or daily oral alendronate, can maintain the bone density improvements achieved with denosumab in postmenopausal women with osteoporosis. Participants who have been on denosumab for at least three years wi…
Sponsor: 424 General Military Hospital • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
New CML drug combo strategy aims for deeper remission without lifelong side effects
Disease control OngoingThis study tests a new drug, asciminib, as the first treatment for adults newly diagnosed with chronic myeloid leukemia (CML). If the drug alone does not achieve a deep response within 2 to 3 years, a low dose of another targeted therapy is added. The goal is to see if this appro…
Phase 2 • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Can a biologic drug outperform standard therapy for a rare blood cancer?
Disease control OngoingThis phase 3 trial compares the biologic drug P1101 (ropeginterferon alfa-2b) against the standard drug anagrelide in people with essential thrombocythemia, a rare blood cancer that causes too many platelets. The study enrolls adults who have not responded well to the first-line …
Phase 3 • Sponsor: PharmaEssentia • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
New hope for rare leukemia: targeted pill shows promise in early trial
Disease control OngoingThis study tests a drug called cobimetinib in people with a rare blood cancer (CMML) that has certain gene mutations. The goal is to see if the drug can shrink or control the cancer. Fourteen adults with either new or treatment-resistant CMML will take the drug daily in 3-week-on…
Phase 2 • Sponsor: University of Utah • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Can pressurized oxygen boost cord blood transplants?
Disease control OngoingThis study tests whether giving patients hyperbaric oxygen (breathing pure oxygen in a pressurized chamber) after an umbilical cord blood stem cell transplant helps the donated stem cells grow faster. The trial enrolls people with blood cancers like leukemia or lymphoma who lack …
Phase 2 • Sponsor: University of Rochester • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
New combo pill shows promise for rare bone marrow cancer
Disease control OngoingThis Phase 3 trial tests whether adding pelabresib to the standard drug ruxolitinib works better than ruxolitinib alone for people with myelofibrosis, a rare bone marrow disorder. About 430 adults who have not had prior JAK inhibitor treatment will take either the combination or …
Phase 3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Could a simple drug during brain surgery prevent Life-Threatening sodium swings?
Disease control By invitation onlyThis trial tests whether giving a low-dose infusion of desmopressin (dDAVP) during surgery for complex brain tumors around the pituitary gland can prevent dangerously high sodium levels (hypernatremia) in the first 24 hours after surgery. High sodium can cause brain bleeding, sei…
Phase 4 • Sponsor: Zhaoyun Zhang • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Psoriasis drug bimekizumab: new study looks at gene changes
Disease control OngoingThis study tests the drug bimekizumab in 89 adults with moderate to severe plaque psoriasis, some of whom also have psoriatic arthritis. Researchers will measure changes in gene activity in skin samples after 48 weeks of treatment. The goal is to understand how the drug affects t…
Phase 3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Own stem cells Gene-Hacked to fight rare hurler syndrome
Disease control OngoingThis study tests a one-time gene therapy for children with Hurler syndrome, a severe genetic disorder. Doctors take the child's own blood stem cells, add a working copy of the missing gene, and put them back. The goal is to help the body produce the enzyme it lacks, potentially s…
Phase 1/2 • Sponsor: Orchard Therapeutics • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Can a drug free myelofibrosis patients from frequent blood transfusions?
Disease control OngoingThis phase 3 study tests whether the drug luspatercept can help people with myelofibrosis-related anemia become independent of red blood cell transfusions. Participants are adults with myelofibrosis who are already taking a JAK inhibitor and need regular transfusions. The study c…
Phase 3 • Sponsor: Celgene • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Could a triple therapy tackle diabetes, high blood pressure, and arthritis at once?
Disease control CancelledThis study investigates whether adding two common drugs—valsartan (for high blood pressure) and celecoxib (for arthritis pain)—to standard metformin therapy can improve blood sugar control in people with type 2 diabetes. The trial enrolls adults with obesity, high blood pressure,…
Phase 1/2 • Sponsor: ARKAY Therapeutics • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Could a daily pill boost growth in kids with hypochondroplasia?
Disease control By invitation onlyThis study tests an oral drug called infigratinib in children with hypochondroplasia, a condition that causes short stature. The trial has two parts: first, all children receive the drug to see if it safely increases their growth rate; then, some will switch to a placebo to confi…
Phase 2/3 • Sponsor: QED Therapeutics, a BridgeBio company • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
New hope for FSHD: Long-Term drug safety trial underway
Disease control OngoingThis study is for people with FSHD, a genetic disease that causes muscle weakness. It tests the long-term safety and how well the body tolerates a drug called AOC 1020, given through a vein. About 84 adults who completed a previous study will take part. The main goal is to check …
Phase 2 • Sponsor: Avidity Biosciences, Inc. • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Could a pill replace infusions for gaucher brain symptoms?
Disease control OngoingThis phase 2 trial tests an oral drug called venglustat, given alongside the standard enzyme therapy Cerezyme, in adults with Gaucher disease type 3 (a rare genetic disorder affecting the body and brain). The study has four parts: first, it checks spinal fluid biomarkers to disti…
Phase 2 • Sponsor: Genzyme, a Sanofi Company • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Which shoulder surgery works best for seniors with arthritis? a Head-to-Head trial
Disease control OngoingThis study compares two types of shoulder replacement surgery—Total Shoulder Arthroplasty (TSA) and Reverse Total Shoulder Arthroplasty (RTSA)—in people aged 65 and older with advanced shoulder osteoarthritis. Participants are randomly assigned to one of the two procedures. The g…
Sponsor: University of Alberta • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Can a 4-Minute chat rival a Dietitian's hour for heart health?
Disease control OngoingThis study tests whether a short, standardized 4-minute heart-healthy talk is as effective as a full 60-minute personalized session with a dietitian for lowering LDL cholesterol and improving diet. Participants are adults aged 30–80 with rheumatoid arthritis, psoriatic arthritis,…
Sponsor: Diakonhjemmet Hospital • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Patients choose: transplant or Non-Transplant for rare bone marrow cancer?
Disease control OngoingThis study looks at two treatment options for people with a high-risk form of myelofibrosis, a rare bone marrow cancer. Participants choose whether they want a stem cell transplant or the best non-transplant treatments available. Researchers then track survival and quality of lif…
Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Withdrawn study sought to boost RA remission with education and team care
Disease control CancelledThis study was designed to test whether a combination of an educational booklet, team-based care from a rheumatologist, physical therapist, and psychologist, plus nurse-led phone calls and home symptom tracking, could help more Hispanic adults with rheumatoid arthritis achieve re…
Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Engineered t cells with a kill switch aim to make stem cell transplants safer
Disease control OngoingThis study tests a new approach for people receiving a stem cell transplant from a partially matched family donor. The donor's immune cells (T cells) are modified in the lab to include a 'suicide gene' that can be activated by a drug if the cells attack the patient's body, causin…
Phase 1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
3D-Printed spinal cages could revolutionize back surgery
Disease control OngoingThis study compares two types of implants used in spinal fusion surgery: 3D-printed cages and titanium-coated cages. The goal is to see which leads to better bone fusion and less disability for patients with herniated discs or degenerative spine disease. About 78 adults undergoin…
Sponsor: Aesculap AG • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Smart dosing strategy could keep rheumatoid arthritis under control
Disease control OngoingThis study compares two ways of managing rheumatoid arthritis in people taking adalimumab. One group gets standard care, while the other has their dose adjusted based on regular blood tests that measure drug levels and antibodies. The goal is to see if personalized dosing helps m…
Phase 4 • Sponsor: Diakonhjemmet Hospital • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Suicide Gene-Equipped t cells aim to make stem cell transplants safer
Disease control OngoingThis trial tests whether specially modified T cells from a partially matched donor can help patients recover their immune system faster after a stem cell transplant. The T cells are engineered with a 'suicide gene' that allows doctors to destroy them if they cause graft-versus-ho…
Phase 1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
One-Time gene therapy aims to halt rare, fatal brain disease in children
Disease control OngoingThis study tests a single dose of PBGM01, a gene therapy delivered directly into the fluid around the brain and spinal cord, in children with GM1 gangliosidosis. The therapy uses a harmless virus to carry a working copy of the GLB1 gene, which is missing or faulty in these patien…
Phase 1/2 • Sponsor: Gemma Biotherapeutics • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New drug combo aims to control rare leukemia without harsh chemo
Disease control OngoingThis Phase 3 trial tests whether adding ivosidenib (a targeted pill) to standard azacitidine helps adults with a specific IDH1-mutated acute myeloid leukemia (AML) who cannot have intensive chemotherapy. About 146 participants receive either the combo or a placebo plus azacitidin…
Phase 3 • Sponsor: Institut de Recherches Internationales Servier • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Childhood leukaemia trial seeks best chemo cocktail
Disease control OngoingThis trial investigates the best way to treat children with acute myeloid leukaemia (AML) by comparing different chemotherapy drugs and doses. It tests whether adding up to three doses of the targeted drug gemtuzumab ozogamicin to standard chemo is safe and effective. The study a…
Phase 3 • Sponsor: University of Birmingham • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Robot suit aims to get paralyzed patients back on their feet
Disease control OngoingThis study tests whether a robotic exoskeleton called ReWalk can help people with complete spinal cord injury below T4 walk and improve their health. Fifty participants will either use the exoskeleton or receive standard physical therapy. The goal is to see if the device improves…
Sponsor: University of Pecs • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
New combo aims to boost survival in older AML patients
Disease control OngoingThis phase 3 trial compares a two-drug combination (pevonedistat plus azacitidine) against azacitidine alone in 302 older or unfit adults newly diagnosed with acute myeloid leukemia (AML) who cannot have standard intensive chemotherapy. The main goal is to see if the combination …
Phase 3 • Sponsor: PETHEMA Foundation • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
New dissolving nasal dressing could improve sinus surgery recovery
Disease control By invitation onlyThis study compares a new biodegradable nasal dressing that slowly releases a steroid (mometasone furoate) to a standard steroid-releasing stent, both used after sinus surgery. About 110 adults with chronic sinusitis (with or without nasal polyps) will receive the new dressing in…
Sponsor: Polyganics BV • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Could a few shots replace weeks of IV antibiotics for joint infections?
Disease control OngoingThis study tests dalbavancin, a long-acting antibiotic given as a few shots over two months, for infections that occur after hip or knee replacement surgery. The standard treatment requires 12 weeks of daily antibiotics, which can be hard to tolerate and complete. The trial inclu…
Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Promising combo offers hope for older AML patients
Disease control OngoingThis phase 3 study tested whether adding venetoclax to azacitidine helps people with untreated acute myeloid leukemia (AML) who cannot receive standard chemotherapy. About 443 adults took part, with two-thirds receiving the drug combo and one-third getting a placebo plus azacitid…
Phase 3 • Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Stem cells and 3D printing join forces to mend broken bones and arthritic knees
Disease control OngoingThis study tests a combination of a patient's own stem cells and platelet-rich plasma to help heal broken bones that won't mend on their own and to treat knee arthritis. For people needing a knee replacement, doctors use custom 3D-printed guides made from the patient's scans to i…
Sponsor: Zaporizhzhiya State Medical University • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Invisible hearing: new cochlear implant needs no external parts
Disease control OngoingThis study tests a new totally implantable cochlear implant system (TICI G2) that has a microphone under the skin, so you can hear without any external devices. Researchers will enroll 18 adults with sensorineural hearing loss to see how well the internal microphone works over ti…
Sponsor: Cochlear • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Real-World study tests upadacitinib for back pain in axial spondyloarthritis
Disease control OngoingThis study looks at how well upadacitinib (RINVOQ) works for people with axial spondyloarthritis, a type of inflammatory arthritis that causes chronic back pain. About 338 adults in Germany will take the drug as prescribed by their doctor and be followed for 52 weeks. Researchers…
Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
New RA pill takes on tofacitinib in Head-to-Head trial
Disease control OngoingThis phase 3 trial tests whether a new oral drug called TLL-018 works better than tofacitinib for active rheumatoid arthritis. The study includes 459 adults aged 18-65 who have not responded well to or cannot tolerate biologic treatments. Participants take either TLL-018 or tofac…
Phase 3 • Sponsor: Hangzhou Highlightll Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New drug combo aims to tame Cushing's disease with fewer side effects
Disease control By invitation onlyThis study tests whether adding cabergoline to osilodrostat works better than osilodrostat alone for controlling Cushing's disease. About 50 adults with active Cushing's disease will receive either the combination or the single drug. The goal is to see if the combo can lower cort…
Phase 4 • Sponsor: University of Basrah • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New implant aims to strengthen shoulder tendon repair after replacement
Disease control OngoingThis study is testing a special implant (Tapestry) that helps repair a key shoulder tendon (subscapularis) during shoulder replacement surgery. About 100 adults with shoulder arthritis or injury will be followed for 2 years to see if the tendon heals better with the implant. The …
Sponsor: Zimmer Biomet • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Hip implant study pulled before it even started
Disease control CancelledThis study planned to test a hip implant called the Restoration Anatomic Acetabular Shell in people needing revision surgery after a previous hip replacement failed. The goal was to see how well the implant holds up over time. However, the study was withdrawn before enrolling any…
Sponsor: Stryker Orthopaedics • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New combo therapy for AML enters early human testing
Disease control OngoingThis early-phase study tests a new drug called cusatuzumab alongside usual treatments for adults with acute myeloid leukemia (AML) who cannot have intensive chemotherapy. The main goal is to check the safety and side effects of the combination. About 61 participants will receive …
Phase 1 • Sponsor: OncoVerity, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Can 'Zombie Cell' drugs strengthen aging bones?
Disease control OngoingThis Phase 2 trial tests whether a combination of three drugs—dasatinib, quercetin, and nicotinamide riboside—can improve bone health in 120 adults aged 60-90 with osteopenia or osteoporosis. The goal is to see if these 'senolytic' drugs can clear aging cells from the skeleton an…
Phase 2 • Sponsor: Odense University Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New hope for hard-to-treat blood cancers: experimental drug imetelstat tested in phase 2 trial
Disease control OngoingThis study tests an experimental drug called imetelstat in 46 adults with high-risk myelodysplastic syndromes or acute myeloid leukemia that did not improve after standard therapy. The goal is to see if the drug can improve blood cell counts and control the disease. Participants …
Phase 2 • Sponsor: GCP-Service International West GmbH • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
One surgery instead of two? new coating may fight hip implant infections
Disease control OngoingThis study compares a single-stage surgery using implants coated with an antibiotic-loaded hydrogel to the standard two-stage surgery for treating chronic hip prosthesis infections. The single-stage approach aims to remove the infected implant and place a new one in the same oper…
Sponsor: Centre Hospitalier Universitaire de Saint Etienne • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
New hope for older blood cancer patients: smarter transplants aim to cut relapse
Disease control OngoingThis clinical trial is testing different treatment strategies to improve outcomes for older adults with acute myeloid leukemia (AML) or high-risk myelodysplastic syndrome (MDS) who are getting a stem cell transplant. The study compares a new pre-transplant drug (Vyxeos) with stan…
Phase 2/3 • Sponsor: University of Birmingham • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Leukemia drug holiday: study tests if patients can pause treatment
Disease control OngoingThis study looks at whether people with chronic myeloid leukemia (CML) who have had a stable, deep response to treatment for at least two years can safely stop taking their daily targeted therapy (TKI). It involves 17 adults who have been on TKI for over three years. The main goa…
Phase 2 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Shorter treatment course may ease side effects for AML patients
Disease control OngoingThis study tests a new way of giving two drugs—venetoclax and azacitidine—to adults with acute myeloid leukemia (AML) who are not healthy enough for standard chemotherapy. Instead of the usual 7 days of azacitidine, this approach uses only 5 days per cycle to try to reduce infect…
Phase 2 • Sponsor: University of Leipzig • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Can a Nurse-Led program transform Women's health in hong kong?
Disease control OngoingThis trial tests a nurse-led health program for women aged 45 to 64 in Hong Kong. The program uses a 5-step approach (ask, advice, assess, assist, arrange) to help women manage conditions like high blood pressure, anxiety, and menopause symptoms. Researchers will compare the prog…
Sponsor: The University of Hong Kong • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Better ankle implant aims to last longer and reduce pain
Disease control OngoingThis study follows 200 people who received a new type of ankle replacement designed to attach better to bone and wear out more slowly. Researchers will track pain, function, and how long the implant lasts over time. The goal is to see if this improved device helps people with sev…
Sponsor: Northumbria Healthcare NHS Foundation Trust • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New combo therapy targets tough blood cancers in early trial
Disease control OngoingThis study tests a new drug called bexmarilimab, given together with standard treatments, for people with certain blood cancers (MDS, CMML, or AML). The goal is to first find a safe dose and then see if the combination helps shrink or control the cancer. About 181 adults are taki…
Phase 1/2 • Sponsor: Faron Pharmaceuticals Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
AI app takes on scoliosis: could your phone replace physical therapy?
Disease control OngoingThis study tests whether a smartphone app that uses artificial intelligence can help teens with scoliosis do better exercises than traditional physical therapy. The app analyzes posture and creates a personalized workout plan. Researchers will compare spine curve changes and how …
Sponsor: Jinan University Guangzhou • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New drug combo aims to rebuild bone in spinal cord injury patients
Disease control OngoingThis study tests whether a two-step drug treatment can improve bone density in people with long-term spinal cord injury who have bone loss. Participants receive either romosozumab (a bone-building drug) or a placebo for 12 months, followed by denosumab (a bone-strengthening drug)…
Phase 2 • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
New combo treatment aims to save hips from collapse
Disease control OngoingThis study tests a procedure for people with early-stage osteonecrosis (bone death) of the hip. Doctors drill into the hip bone, inject a concentrated sample of the patient's own bone marrow, and add a special bone graft material called Genex. The goal is to see if this helps bon…
Sponsor: The Cleveland Clinic • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Could a tiny neck implant calm rheumatoid arthritis without pills?
Disease control OngoingThis study tests a small device implanted on the vagus nerve in the neck to treat moderate to severe rheumatoid arthritis. About 243 adults who did not get enough relief from standard drugs will receive either active or inactive stimulation for 12 weeks, then all will receive act…
Phase 3 • Sponsor: SetPoint Medical Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Last-Resort treatment for joint infections now available
Disease control Expanded access (paused)This program provides access to the VT-X7 system, which delivers antibiotics directly into the joint through a pump over 7 days, for people with a serious hip or knee infection after joint replacement. It is for patients who have already tried other treatments and have no other o…
Sponsor: Osteal Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New combo shows promise for Tough-to-Treat leukemia
Disease control By invitation onlyThis study tests a combination of three drugs (homoharringtonine, venetoclax, and azacitidine) in 40 adults newly diagnosed with a rare and aggressive leukemia called mixed-phenotype acute leukemia (MPAL). The goal is to see if this drug combo can safely help more patients achiev…
Phase 2 • Sponsor: Guangdong Second Provincial General Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New softer cement could reduce repeat spine fractures
Disease control OngoingThis study compares two bone cements used to treat painful spinal fractures caused by osteoporosis. One cement includes a softener (V-Flex) to make it less rigid, while the other is standard cement (V-Steady). The goal is to see if the softer cement reduces the chance of new frac…
Sponsor: Inossia AB • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Which airway method saves more kids? major trial aims to find out
Disease control PausedThis study tests three ways emergency responders help children breathe: a bag-mask, a throat tube, or a breathing tube. It includes 3,000 children under 18 with cardiac arrest, severe injury, or breathing failure. The goal is to see which method leads to more days alive and out o…
Sponsor: Ohio State University • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New shoulder replacement system tracked in global study
Disease control By invitation onlyThis study is following 110 people who received a Tornier HRS shoulder replacement to see how well it improves pain and function. Participants have conditions like arthritis, fractures, or rotator cuff tears. The goal is to collect long-term safety and performance data for regula…
Sponsor: Stryker Trauma and Extremities • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
New combo therapy aims to halt prostate cancer spread
Disease control OngoingThis phase II trial tests whether adding the immunotherapy drug durvalumab to precise radiation (SBRT) can better control prostate cancer that has returned and spread to a few spots (oligometastases). About 96 men with hormone-sensitive prostate cancer will be randomly assigned t…
Phase 2 • Sponsor: Institut Cancerologie de l'Ouest • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
New drug aims to stop hip bone death from steroids
Disease control OngoingThis study tests a new drug called RAB001 in people with early-stage hip bone damage caused by long-term steroid use. About 160 participants will receive either a low, medium, or high dose of RAB001, or a standard bone drug (alendronate). The goal is to see if RAB001 can reduce t…
Phase 2 • Sponsor: ZhongShan LaiBo RuiChen BioMedicine Co.,Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Double-Drug attack on rheumatoid arthritis shows promise in new trial
Disease control OngoingThis Phase III trial tests whether combining baricitinib with an anti-TNF drug (adalimumab or etanercept) works better than baricitinib alone for people with rheumatoid arthritis who haven't responded to prior treatments. The study involves 160 adults aged 18-65 with active disea…
Phase 3 • Sponsor: University Hospital, Bordeaux • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New hope for blood cancer patients: using mismatched donors for transplants
Disease control OngoingThis study tests a stem cell transplant using donors who are not a perfect match for patients with blood cancers like leukemia and lymphoma. Doctors give special drugs after the transplant to help prevent the donor cells from attacking the patient's body. The goal is to see if th…
Phase 2 • Sponsor: Center for International Blood and Marrow Transplant Research • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Casting vs bracing: which works best for kids with curved spines?
Disease control OngoingThis study compares two treatments—casting and bracing—for children under 3 with early-onset scoliosis. The goal is to see which method better controls spine curvature and improves quality of life. About 71 children and their parents are taking part.
Sponsor: University of Iowa • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Hope for growth: new drug shows promise in Long-Term achondroplasia study
Disease control OngoingThis study looks at the long-term safety and effects of a daily injection called BMN 111 in children with achondroplasia, a common form of dwarfism. It includes 30 children who have already taken the drug for two years in a previous study. The goal is to see if the drug remains s…
Phase 2 • Sponsor: BioMarin Pharmaceutical • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New knee implant tracked for 10 years – will it last?
Disease control OngoingThis study follows 148 people with knee osteoarthritis who received the ANTHEM total knee replacement system. Researchers will check how well the implant holds up over 10 years by measuring survival rates and patient-reported knee function. The goal is to confirm the device is as…
Sponsor: Smith & Nephew, Inc. • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New knee replacement system under study for arthritis patients
Disease control OngoingThis study looks at how safe and effective the ANTHEM CR total knee system is for people with non-inflammatory degenerative joint disease who need a total knee replacement. About 153 participants will be followed for up to 10 years to check implant survival, bone health, and any …
Sponsor: Smith & Nephew Pte Ltd • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Could a Double-Dose of antibiotics in bone cement prevent infections after hip surgery?
Disease control OngoingThis study compares two types of antibiotic-loaded bone cement used during hip fracture surgery to see which better prevents joint infections. About 7000 patients aged 60 and older with displaced femoral neck fractures will be included. Hospitals are randomly assigned to use eith…
Phase 3 • Sponsor: Umeå University • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New drug combo aims to wipe out leukemia cells in High-Risk patients
Disease control OngoingThis phase 2 trial tests whether adding daratumumab, an antibody that targets a protein on leukemia cells, to standard chemotherapy can clear all signs of cancer in adults with very high-risk T-cell acute lymphoblastic leukemia (T-ALL). About 31 patients aged 18-65 will receive t…
Phase 2 • Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
New drug cocktail shows promise for rare leukemia
Disease control OngoingThis study tests a combination of two drugs, azacitidine and venetoclax, in people with a high-risk form of chronic myelomonocytic leukemia (CMML). The goal is to see if the combo can shrink or control the cancer better than current treatments. About 44 adults will take part, and…
Phase 2 • Sponsor: Groupe Francophone des Myelodysplasies • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
CAR-T cells take on rheumatoid arthritis in Head-to-Head trial
Disease control OngoingThis phase I/II trial compares a single dose of CAR-T cell therapy (KYV101) to two doses of rituximab in 13 people with active, treatment-resistant rheumatoid arthritis. The main goals are to check safety and see if the CAR-T treatment can turn off certain immune markers linked t…
Phase 1/2 • Sponsor: Charite University, Berlin, Germany • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New study tests simpler dental implant method to avoid extra surgery
Disease control OngoingThis study compares two ways to place dental implants in people with bone loss. One technique places the implant at the gum level (tissue-level), while the other places it at the bone level and requires a second surgery to uncover it. Researchers will track bone changes, implant …
Sponsor: University of Bologna • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Vitamin e in knee implants: a Long-Term showdown
Disease control OngoingThis study looks at two kinds of plastic used in total knee replacement surgery: one with vitamin E and one without. The goal is to see which one lasts longer, causes less wear, and helps patients move better. About 605 adults with knee arthritis or similar problems took part, an…
Sponsor: Aesculap AG • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Knee device under review: will it stand the test of time?
Disease control OngoingThis study looks at how well a specific knee replacement device, the Triathlon All-Polyethylene Tibia, works in people with knee arthritis. Researchers will follow 204 patients who already have the device to see how their knee function and pain change over time. The goal is to ch…
Sponsor: Stryker Orthopaedics • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Could a 'Sinus poop Transplant' cure chronic sinusitis? new trial says maybe.
Disease control OngoingThis study tests a new treatment for chronic sinusitis, a long-lasting sinus infection that doesn't get better with standard care. Researchers will take healthy bacteria from a donor's sinuses and transfer them into the sinuses of 80 patients, after a special sinus wash. The goal…
Sponsor: Amin Javer • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
New drug aims to slash fractures in brittle bone disease
Disease control OngoingThis study tests a medicine called setrusumab in people with osteogenesis imperfecta (brittle bone disease). The goal is to see if it can lower the number of bone fractures. About 183 participants with types I, III, or IV of the disease who have had recent fractures will receive …
Phase 2/3 • Sponsor: Ultragenyx Pharmaceutical Inc • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Hip replacement stem under review: 5-Year safety and performance study
Disease control OngoingThis study looks at the safety and performance of a cemented hip stem (TrendHip®) in 119 people who had hip replacement surgery. It tracks pain, function, and quality of life for up to 5 years after surgery. The goal is to confirm the device works well in everyday use.
Sponsor: Aesculap AG • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
New drug aims to cut fractures in kids with brittle bones
Disease control OngoingThis study tests a new medicine called setrusumab against standard bone-strengthening drugs (bisphosphonates) in children aged 2 to under 7 with osteogenesis imperfecta (brittle bone disease) types I, III, or IV. The goal is to see if setrusumab can lower the number of bone break…
Phase 3 • Sponsor: Ultragenyx Pharmaceutical Inc • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
New drug combo aims to boost growth in kids with dwarfism
Disease control OngoingThis study tests whether giving two weekly injections together can improve growth in children aged 2 to 11 with achondroplasia, a common cause of dwarfism. The drugs, navepegritide and lonapegsomatropin, are designed to increase height. The trial will measure growth rate and moni…
Phase 2 • Sponsor: Ascendis Pharma Growth Disorders A/S • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New spine device aims to fix crooked necks
Disease control OngoingThis study is testing a new surgical system called Symphony for adults with severe neck deformities. About 100 patients will receive the device to straighten the spine and relieve pain. Researchers will track pain, disability, and complications for up to two years.
Sponsor: International Spine Study Group Foundation • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Can a smartphone app tame your allergies?
Disease control By invitation onlyThis study tests whether digital tools can help people with allergic rhinitis (hay fever) better control their symptoms. About 240 adults will use a smartphone platform that tracks symptoms, sends reminders, and gives personalized advice. Researchers will compare their progress t…
Sponsor: QHSLab, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
New Bone-Boosting drug shows promise for osteoporosis
Disease control OngoingThis study tests an experimental drug called AGA2118 in postmenopausal women aged 55 to 80 who have low bone density but no history of fractures. The goal is to see if the drug can safely increase bone mineral density over 12 months compared to a placebo. About 379 women will par…
Phase 2 • Sponsor: Angitia Biopharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
New knee implant under review: will it hold up?
Disease control OngoingThis study follows 100 people who received a new type of knee replacement device called EVOLUTION® NitrX™. The goal is to see how safe and effective it is over time. Participants have conditions like arthritis or knee damage. The main measure is a patient-reported score of knee f…
Sponsor: MicroPort Orthopedics Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
One surgery to fix two knee problems? pilot study tests combo approach
Disease control By invitation onlyThis pilot study looks at combining two knee surgeries into one: a partial knee replacement and an ACL repair. It aims to see if doing both at the same time is safe and effective for people with knee arthritis and a torn ACL. The study will collect data from 15 patients to measur…
Sponsor: Istituto Ortopedico Rizzoli • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Gum disease breakthrough? blood concentrate shows promise in small trial
Disease control OngoingThis study tested whether adding injectable Platelet-Rich Fibrin (i-PRF), a natural concentrate from a patient's own blood, to standard deep cleaning improves gum disease outcomes. In 13 adults with moderate to severe periodontitis, one side of the mouth received the combined tre…
Sponsor: Al-Mustansiriyah University • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Remote Follow-Up for pituitary tumors: safe or risky?
Disease control By invitation onlyThis study compares the safety of routine telephone or video follow-ups versus in-person visits for patients with non-functioning pituitary tumors. Over two years, 812 participants will be randomly assigned to remote or in-person check-ups. The goal is to see if remote follow-up …
Sponsor: Zealand University Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Knee implant study tracks 10-Year performance
Disease control OngoingThis study looks at how well a specific knee replacement implant works over 10 years. Researchers are checking the safety and performance of the Legion knee implant in 126 people who already received it. The goal is to see how long the implant lasts and if it helps patients with …
Sponsor: Smith & Nephew, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New daily pill could simplify tough bone infection treatment
Disease control OngoingThis study tests a new antibiotic called omadacycline, taken once a day by mouth, against standard antibiotics for bone and joint infections. About 180 adults with these infections will be randomly assigned to receive either omadacycline or the usual care. The goal is to see if o…
Phase 2 • Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New study tracks leukemia Drug's Real-Life impact
Disease control OngoingThis study follows about 100 adults with acute myeloid leukemia (AML) who are already prescribed venetoclax by their doctors in Israel. Researchers will track how long patients live and how many achieve remission during routine care. The goal is to understand the drug's real-worl…
Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Shorter antibiotic course for diabetic foot infection tested – but trial never started
Disease control CancelledThis study aimed to see if a 3-week course of antibiotics works as well as a 6-week course for treating bone infections in the feet of people with diabetes. The trial planned to include adults with diabetes and a forefoot bone infection treated without surgery. However, the study…
Phase 3 • Sponsor: Tourcoing Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Gene-Edited super cells take on childhood leukemia
Disease control OngoingThis early-stage trial tests a new treatment for children aged 6 months to 16 years whose acute myeloid leukemia has returned. The therapy uses donor immune cells that have been gene-edited with a technique called base editing to better target and kill leukemia cells. The main go…
Phase 1 • Sponsor: Great Ormond Street Hospital for Children NHS Foundation Trust • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
New hope for rare blood cancer: drug duo targets enlarged spleen
Disease control OngoingThis study tests whether adding the experimental drug navitoclax to the standard drug ruxolitinib can shrink the spleen and reduce symptoms better than other available treatments in adults with myelofibrosis that has returned or not improved. About 330 participants will be random…
Phase 3 • Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Knee surgery showdown: partial vs. total replacement for arthritis
Disease control OngoingThis study compares two types of knee replacement surgery for people with arthritis limited to the kneecap area. One hundred patients will be randomly assigned to receive either a partial replacement (patellofemoral arthroplasty) or a full knee replacement. The goal is to see whi…
Sponsor: University of Aarhus • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Pharmacists take on heart disease: new study tests community-based risk reduction
Disease control OngoingThis study tests whether a pharmacist-led program can help people reduce their risk of heart disease. Over 1,000 adults with conditions like diabetes, high blood pressure, or obesity are taking part. Pharmacists use a step-by-step guide to assess risk and support lifestyle change…
Sponsor: University of Alberta • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
New drug combo targets tough leukemia in early trial
Disease control OngoingThis study tests a new combination of two drugs (gemtuzumab ozogamicin and gilteritinib) for adults with a specific genetic form of acute myeloid leukemia (AML) that has come back or not responded to treatment. The trial aims to see if the combination is safe and helps control th…
Phase 2 • Sponsor: Centre Antoine Lacassagne • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
New spine surgery aims to straighten scoliosis in teens
Disease control OngoingThis study tests a spine surgery for 20 teenagers (ages 12-21) with a specific type of scoliosis called Lenke 1. The goal is to correct the spine curve and improve quality of life. Researchers will measure how well the surgery works using X-rays and patient questionnaires.
Sponsor: Istituto Ortopedico Rizzoli • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
3D printing and plasma team up to fix knee cartilage
Disease control OngoingThis study tests a new way to repair damaged knee cartilage using 3D printing, platelet-rich plasma, and a piece of the patient's own bone and tissue. It involves 60 adults with large cartilage injuries. The goal is to see if this approach improves knee function and helps cartila…
Sponsor: Second Affiliated Hospital of Nanchang University • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Spine implant showdown: which material fuses best?
Disease control By invitation onlyThis study follows 300 adults aged 18-80 who need spinal fusion surgery for degenerative disc disease or spondylolisthesis. It compares three types of interbody implants (PEEK, 3D-printed titanium, and another) used with bone graft material. Researchers will track how well the bo…
Sponsor: NuVasive • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Gene therapy could replace risky transplants for kids with hurler syndrome
Disease control OngoingThis Phase 3 trial tests a new gene therapy called OTL-203 against the standard stem cell transplant for children with Hurler syndrome, a rare genetic disorder. The therapy uses the child's own blood stem cells, modified to produce the missing enzyme, aiming to improve survival a…
Phase 3 • Sponsor: Orchard Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Can a common arthritis drug ease hand pain? new study investigates
Disease control OngoingThis study tests whether methotrexate, a drug used for other types of arthritis, can reduce pain and improve hand function in people with a severe form of hand osteoarthritis. About 163 adults with moderate to severe finger pain will receive either methotrexate or a placebo for 6…
Phase 4 • Sponsor: Diakonhjemmet Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
New RNA drug aims to reduce blood removal in polycythemia vera patients
Disease control OngoingThis study tests a new drug called SLN124 in 69 adults with polycythemia vera, a condition where the body makes too many red blood cells. The drug works by blocking a protein that controls iron use, which may lower red blood cell production and reduce the need for regular blood r…
Phase 1/2 • Sponsor: Silence Therapeutics plc • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Targeted radiation may extend life for patients with limited bone metastases
Disease control OngoingThis study looks at whether adding a high-precision type of radiation called SBRT to usual cancer treatments (like hormone therapy or chemo) can delay cancer growth in people with breast, lung, or prostate cancer that has spread to 1 to 5 bones. About 168 adults aged 18-75 with g…
Sponsor: UNICANCER • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Canadian study monitors Venetoclax's Real-World impact on AML
Disease control OngoingThis study looks at how well the drug venetoclax works for adults with acute myeloid leukemia (AML) who cannot handle strong chemotherapy. About 210 people across Canada will take venetoclax pills daily as part of their normal care. Researchers will track their overall survival a…
Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Experimental CAR-T therapy targets tough leukemia
Disease control PausedThis early-stage trial is testing a new treatment called CT0991, which uses specially engineered immune cells (CAR-T cells) to fight acute myeloid leukemia (AML) that has come back or not responded to standard therapy. The study involves 24 adults aged 18-75 and aims to check saf…
Phase 1 • Sponsor: He Huang • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
New shoulder implant tested for arthritis and rotator cuff tears
Disease control OngoingThis study is testing a shoulder replacement device called the Medacta Shoulder System in 100 people with shoulder arthritis or rotator cuff tears. The goal is to see how well the implant works after 2 years, focusing on shoulder function, safety, and patient satisfaction. Partic…
Sponsor: University Hospital, Tours • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
New drug combo may let CML patients pause treatment
Disease control OngoingThis phase 2 trial tests whether starting with a stronger drug (ponatinib) for 6 months, then switching to a standard drug (imatinib) for at least 30 months, can help adults with newly diagnosed chronic myeloid leukemia reach deep remission. The goal is to see if patients can the…
Phase 2 • Sponsor: Centre Leon Berard • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Vitamin e in hip implants: a Longer-Lasting fix?
Disease control OngoingThis study compares two types of hip implant liners—one with vitamin E and one without—to see which lasts longer and causes fewer problems like wear or bone damage. Researchers are following 400 adults aged 18 to 75 who need a hip replacement due to arthritis. The goal is to find…
Sponsor: Aesculap AG • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New chemo combo aims to boost leukemia survival after transplant
Disease control OngoingThis phase 2 trial tests a combination of two chemotherapy drugs, fludarabine and treosulfan, given before a stem cell transplant in adults aged 40-65 with acute myeloid leukemia (AML) in remission. The goal is to see if this conditioning regimen improves the chance of being aliv…
Phase 2 • Sponsor: Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Phone app aims to ease arthritis after knee injuries
Disease control OngoingThis study tests a telehealth program called mCare PTOA for people who have had ACL knee surgery. The program includes five educational modules on joint health, self-care, weight management, physical activity, and work strategies. Researchers will compare knee function and readin…
Sponsor: Keller Army Community Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Simple scan mistakes may skew osteoporosis diagnoses
Diagnosis OngoingResearchers at a Turkish hospital are studying how errors in bone density scans (DXA) affect doctors' decisions about osteoporosis. They will review scans from 530 adults, identify common positioning mistakes, correct them, and compare the original and corrected results. The goal…
Sponsor: Ankara Etlik City Hospital • Aim: Diagnosis
Last updated Sep 12, 2026 00:00 UTC
-
Can AI turn routine scans into a bone health check?
Diagnosis OngoingThis trial tests whether an AI tool called DeepBMD can identify people at high risk for osteoporosis using CT scans they've already had for other reasons. Researchers will compare the AI's findings with the standard bone density test (DXA) to see if it's accurate. If it works, th…
Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Diagnosis
Last updated Sep 05, 2026 00:00 UTC
-
New scan could replace invasive test for Cushing's disease diagnosis
Diagnosis By invitation onlyThis study compares a new, non-invasive PET-MRI scan to the standard invasive test (IPSS) for finding pituitary tumors in people with Cushing's disease. About 43 adults with confirmed Cushing's will get both tests to see which is more accurate. The goal is to make diagnosis safer…
Sponsor: University Hospital, Basel, Switzerland • Aim: Diagnosis
Last updated Jul 08, 2026 00:00 UTC
-
Bone scanner study pulled before starting: no participants enrolled
Diagnosis CancelledThis study was designed to see if a special bone scanner (bone mineral analyser) could predict how well osteoporotic women would respond to a zoledronic acid infusion. The plan was to measure bone texture and density before and one year after treatment. However, the study was wit…
Sponsor: University Hospital, Rouen • Aim: Diagnosis
Last updated Jun 27, 2026 13:03 UTC
-
No-Radiation bone scan could spot fracture risk early
Diagnosis OngoingThis study tests a new ultrasound device that measures bone properties in the lower leg to predict fracture risk in adults over 55. It aims to see if it works as well as or better than standard DXA scans, without using radiation. Researchers will follow 1,600 participants for thr…
Sponsor: POROUS GmbH • Aim: Diagnosis
Last updated Jun 27, 2026 13:02 UTC
-
New study aims to crack the code on hidden joint infections
Diagnosis OngoingThis study looks at 174 adults with painful joint replacements who may have a chronic infection. Researchers are testing a combination of advanced lab tests, imaging, and tissue sampling to see which methods best detect the infection. The goal is to create a more reliable diagnos…
Sponsor: University Hospital, Ghent • Aim: Diagnosis
Last updated Jun 27, 2026 12:00 UTC
-
Simple checklist could help GPs spot baby hip issues earlier
Diagnosis OngoingThis study tests whether a simple checklist can help general practitioners (GPs) better diagnose developmental dysplasia of the hip (DDH) in babies during routine 6-week checkups. About 172 GP practices in England will be split into two groups: one using the checklist and one con…
Sponsor: Great Ormond Street Hospital for Children NHS Foundation Trust • Aim: Diagnosis
Last updated Jun 27, 2026 08:11 UTC
-
Saliva test could replace complex procedures for Cushing's diagnosis
Diagnosis OngoingThis study aims to see if a simple, inexpensive saliva test can accurately diagnose Cushing's syndrome, a condition where the body makes too much cortisol. Researchers will compare two automated saliva test methods in 380 adults who are already being checked for the condition. Th…
Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Diagnosis
Last updated Jun 27, 2026 07:58 UTC
-
Can a simple rinse stop the most painful complication of wisdom tooth surgery?
Prevention OngoingRemoving an impacted lower wisdom tooth can leave a painful complication called dry socket, where the protective blood clot in the empty socket breaks down. This trial compares two liquids used to rinse the socket right after extraction: normal saline and chlorhexidine, an antise…
Sponsor: CMH Lahore Medical College and Institute of Dentistry • Aim: Prevention
Last updated Sep 16, 2026 00:00 UTC
-
Could exercise be the key to stronger bones in women?
Prevention OngoingThis trial tests whether a year of twice-weekly supervised exercise can improve bone mineral density in women. Researchers will measure bone density and blood markers linked to bone turnover. The goal is to see if regular physical activity can help prevent osteoporosis and relate…
Sponsor: Poznan University of Physical Education • Aim: Prevention
Last updated Sep 06, 2026 00:00 UTC
-
New program aims to cut hip fractures in nursing homes
Prevention OngoingThis study tests a program called PREVENT designed to reduce hip fractures in long-term care homes. The program uses a risk calculator based on residents' health records to identify those at high risk, then trains healthcare staff on the latest fracture prevention recommendations…
Sponsor: McMaster University • Aim: Prevention
Last updated Jul 15, 2026 00:00 UTC
-
Shingles vaccine trial aims to protect vulnerable patients
Prevention OngoingThis study tests the Shingrix vaccine in over 2,000 adults with autoimmune rheumatic diseases like rheumatoid arthritis and lupus, who are at higher risk for shingles. Researchers will compare vaccinated patients to unvaccinated ones to see if the vaccine is safe and triggers a s…
Phase 4 • Sponsor: University of Sao Paulo General Hospital • Aim: Prevention
Last updated Jun 27, 2026 12:29 UTC
-
Eye surgery trial to prevent blindness in stickler syndrome pulled before start
Prevention CancelledThis study aimed to see if a surgical procedure called scleral buckling could prevent retinal detachment in people with Stickler syndrome, a genetic condition that raises the risk of vision loss. The plan was to treat one eye in patients aged 5 to 35 who had already lost vision i…
Phase 2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Prevention
Last updated Jun 27, 2026 12:29 UTC
-
Exercise may shield Women's bones and joints after menopause
Prevention OngoingThis study tests whether a supervised resistance exercise program can reduce the risk of osteoporosis and osteoarthritis in women aged 50-70 who have gone through menopause. Participants will do leg and core exercises twice a week for 30-40 minutes. Researchers will measure chang…
Sponsor: Loughborough University • Aim: Prevention
Last updated Jun 27, 2026 12:23 UTC
-
Anti-Aging drug and football drills join forces to fight brittle bones
Prevention OngoingThis study tests whether a weekly dose of everolimus (a drug that targets aging pathways) and/or a fun exercise program called 'Football Fitness' can prevent the rapid bone loss that happens after menopause. 136 healthy women aged 45-60 will be assigned to one of four groups: exe…
Phase 2 • Sponsor: Odense University Hospital • Aim: Prevention
Last updated Jun 27, 2026 12:04 UTC
-
Bone drug may stop Paget's before it starts in at-risk families
Prevention By invitation onlyThis study follows people who carry a gene mutation that puts them at high risk for Paget's disease of the bone. They previously received either zoledronic acid or a placebo in the ZiPP trial. Now researchers will track them for another 5 years to see if the drug can prevent or d…
Sponsor: University of Edinburgh • Aim: Prevention
Last updated Jun 27, 2026 09:06 UTC
-
New study aims to stop dangerous falls after a broken bone
Prevention By invitation onlyThis study compares three care models to prevent falls and fractures in older adults recovering from a broken bone in a skilled nursing facility. About 3,780 participants across 42 facilities will receive either medication reduction, bone health management, or both. The goal is t…
Sponsor: Duke University • Aim: Prevention
Last updated Jun 27, 2026 08:12 UTC
-
Custom knee guides put to the test in obese patients
Symptom relief OngoingResearchers are comparing two ways to perform total knee replacement in patients with obesity and knee arthritis. One method uses custom-made guides based on each patient's knee scans, while the other uses standard surgical tools. The trial measures how well the knee aligns, how …
Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
Simple knee device may speed up recovery after joint replacement
Symptom relief OngoingThis study tests whether a disposable device called the Zero Degree Knee positioner helps people regain full knee extension faster after total knee replacement surgery. About 154 adults aged 40-80 with knee osteoarthritis will be randomly assigned to use the device at home or fol…
Sponsor: Prisma Health-Midlands • Aim: Symptom relief
Last updated Sep 20, 2026 00:00 UTC
-
One shot, new knee? gene therapy trial aims to quiet arthritis pain
Symptom relief OngoingResearchers are testing FX201, an experimental gene therapy, in adults aged 30 to 80 with painful knee osteoarthritis. Participants receive a single injection of FX201 into the affected knee. The study first checks safety at increasing doses, then gives more people the same dose …
Phase 1 • Sponsor: Pacira Pharmaceuticals, Inc • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Tiny camera may make dental sinus surgery safer
Symptom relief OngoingResearchers compare two ways to lift the sinus floor before placing dental implants in the upper jaw. One method uses a small camera (endoscope) to check the sinus membrane during drilling and grafting, while the other relies on standard techniques. The trial enrolls 24 adults wi…
Sponsor: Nahla Mahmoud Awad • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Mindful movement from home: new study targets knee pain without pills
Symptom relief OngoingThis study tests whether a 10-week telehealth program that combines gentle exercise with mindfulness can help people with knee osteoarthritis feel less pain and move better. Researchers will compare the mindful exercise group to an exercise-only group. All sessions happen remotel…
Sponsor: Boston University Charles River Campus • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Laughing gas vs. oxygen for easier labor induction
Symptom relief CancelledThis study was designed to see if giving nitrous oxide (laughing gas) helps pregnant women feel less pain when a balloon is placed to start labor. It planned to compare nitrous oxide with plain oxygen. However, the study was withdrawn before any participants were enrolled, so no …
Phase 3 • Sponsor: Jefferson Drapkin • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Custom-Shaped nose splint may ease recovery for kids after cleft lip surgery
Symptom relief By invitation onlyChildren who have cleft lip repair or nasal scar release often wear a nasal splint while healing. This trial compares the standard hollow, cone-shaped conformer with a new one shaped to match the inside of the nose. Each child tries both types, switching halfway through, and pare…
Phase 2 • Sponsor: East Tennessee Children's Hospital • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
Can a hydrogel injection ease knee arthritis pain?
Symptom relief OngoingResearchers are observing people with knee osteoarthritis who receive an injection of Arthrosamid, a hydrogel, into the affected knee. The study follows about 200 adults over the long term to track side effects and changes in pain, stiffness, and physical function. Because it is …
Sponsor: Contura • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
Spa therapy tested for knee arthritis relief
Symptom relief OngoingThis study looks at whether a 6-month thermal spa treatment program can meaningfully reduce pain and improve daily function in people with knee osteoarthritis. Researchers will compare results from 76 participants aged 50-80 who receive the spa therapy against an external group r…
Sponsor: CEN Biotech • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
Robots take on knee surgery: could precision mean less pain?
Symptom relief OngoingThis study compares robotic-assisted total knee replacement to the standard manual procedure in 86 adults aged 40-85 with severe knee arthritis. Participants will receive the same knee implant, but one group's surgery is guided by a robotic system. Researchers will measure pain, …
Sponsor: Columbia University • Aim: Symptom relief
Last updated Sep 17, 2026 00:00 UTC
-
Can a Job-Focused rehab program keep arthritis patients employed?
Symptom relief OngoingPeople with rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis often struggle to stay in work. This trial tests a 6-month vocational rehabilitation program called WORK-ON, which includes a coordinating occupational therapist, group sessions with peers, and ind…
Sponsor: The Danish Center for Expertise in Rheumatology • Aim: Symptom relief
Last updated Sep 17, 2026 00:00 UTC
-
Shock waves could soothe sore knees without surgery
Symptom relief CancelledThis study tests whether adding shock wave therapy to a knee strengthening exercise program reduces pain and improves function more than exercise alone in people with knee osteoarthritis. Forty patients with moderate knee pain will be randomly assigned to either exercise only or …
Sponsor: Guadarrama Hospital • Aim: Symptom relief
Last updated Sep 16, 2026 00:00 UTC
-
Massage gun vs. hands: which eases Post-Hip-Surgery numbness?
Symptom relief By invitation onlyAfter hip replacement through a front incision, many people feel numbness, tingling, or burning in the thigh because a nearby nerve gets irritated. This trial tests whether a handheld massage gun, used at home twice a day for six weeks, can ease those symptoms faster than gentle …
Sponsor: Zachary M Ricciardelli • Aim: Symptom relief
Last updated Sep 16, 2026 00:00 UTC
-
New app aims to bridge depression care gap for MS patients
Symptom relief OngoingThis study tests a smartphone app called MS CATCH that lets people with multiple sclerosis regularly report their mood to their neurologist. The goal is to improve how doctors screen and treat depression in MS. About 100 adults with MS and mild-to-moderate depression are taking p…
Sponsor: University of California, San Francisco • Aim: Symptom relief
Last updated Sep 16, 2026 00:00 UTC
-
A personal nurse and a plan: could this ease the daily burden of arthritis?
Symptom relief OngoingThis trial tests a six-month program where a coordinating rheumatology nurse helps people with inflammatory arthritis set goals and plan actions to manage their condition. Participants also get access to physiotherapy, occupational therapy, and social work support as needed. The …
Sponsor: The Danish Center for Expertise in Rheumatology • Aim: Symptom relief
Last updated Sep 13, 2026 00:00 UTC
-
Hip replacement showdown: does the labrum stay or go?
Symptom relief By invitation onlyResearchers are comparing two common surgical approaches during total hip replacement: removing the acetabular labrum (a ring of cartilage around the hip socket) or leaving it in place. The trial enrolls 200 adults with hip osteoarthritis who are scheduled for a primary unilatera…
Sponsor: Total Joint Specialists • Aim: Symptom relief
Last updated Sep 12, 2026 00:00 UTC
-
Can a Nine-Week group program help blood cancer patients grow through trauma?
Symptom relief OngoingResearchers in Greece are testing a nine-session group program called TRANSFORM for people who have finished treatment for blood cancers such as leukemia, lymphoma, and myeloma. The program combines teaching, reflection, coping exercises, and mindfulness to see whether it can spa…
Sponsor: University of West Attica • Aim: Symptom relief
Last updated Sep 12, 2026 00:00 UTC
-
New hope for teens: could a simple infusion cut opioid use after spine surgery?
Symptom relief By invitation onlyThis study looks at whether adding a low-dose dexmedetomidine infusion to standard pain management can lower the amount of narcotics needed and reduce side effects like nausea and itching in teenagers having posterior spinal fusion for scoliosis. About 160 adolescents with idiopa…
Phase 2 • Sponsor: Nichole Doyle • Aim: Symptom relief
Last updated Sep 12, 2026 00:00 UTC
-
Sensor-Aided rehab could transform knee replacement recovery
Symptom relief OngoingThis trial tests whether a wearable sensor that monitors home exercises helps people recover after total knee replacement. Researchers randomly assign 250 adults to either use the sensor or receive standard unsupervised home exercises. The study compares knee function, pain, and …
Sponsor: The Leeds Teaching Hospitals NHS Trust • Aim: Symptom relief
Last updated Sep 12, 2026 00:00 UTC
-
Smart radiation targets cancer pain in bones
Symptom relief PausedThis early study tests a new type of radiation called biology-guided radiation therapy (BgRT) for people with cancer that has spread to the bones and causes pain. BgRT uses live PET scan signals to precisely aim radiation at active tumors during treatment. The goal is to see if a…
Phase 1 • Sponsor: City of Hope Medical Center • Aim: Symptom relief
Last updated Sep 12, 2026 00:00 UTC
-
Gut health fix for aching knees? probiotic trial launches
Symptom relief OngoingThis study tests whether taking probiotic supplements for 6 months can reduce pain, improve knee function, and boost quality of life in women aged 45-70 with knee osteoarthritis. Researchers will compare the probiotic group to a placebo group to see if the gut bacteria help lower…
Sponsor: Lund University • Aim: Symptom relief
Last updated Sep 10, 2026 00:00 UTC
-
Spinal implant shows promise for easing leg pain in older adults
Symptom relief OngoingThis study follows 166 people aged 45 and older who received the Superion IDS implant for lumbar spinal stenosis, a condition that narrows the spine and causes leg pain. The implant is designed to limit certain movements that worsen symptoms. Researchers are checking if patients …
Sponsor: Boston Scientific Corporation • Aim: Symptom relief
Last updated Sep 06, 2026 00:00 UTC
-
Can a tiny catheter cut opioid use after knee surgery?
Symptom relief OngoingThis study compares two ways to manage pain after total knee replacement: a continuous nerve catheter that delivers numbing medicine for days versus a single nerve block. Sixty-four adults scheduled for knee surgery will be randomly assigned to one of the two methods. Researchers…
Sponsor: Hospital for Special Surgery, New York • Aim: Symptom relief
Last updated Sep 05, 2026 00:00 UTC
-
New injection could ease knee arthritis pain without surgery
Symptom relief OngoingThis study tests whether an injected drug called pentosan polysulfate sodium can reduce knee pain and improve function in people with knee osteoarthritis. About 466 adults with moderate to severe knee arthritis who haven't found relief from other treatments will receive either th…
Phase 3 • Sponsor: Paradigm Biopharmaceuticals Ltd. • Aim: Symptom relief
Last updated Sep 03, 2026 00:00 UTC
-
Knee patients try personalized goal program to boost treatment success
Symptom relief OngoingThis study tests a goal-setting program for adults with knee problems like arthritis or injuries. Participants work with their surgeon to create specific, measurable goals and track progress. The aim is to see if this approach helps patients achieve their treatment goals and impr…
Sponsor: Dartmouth-Hitchcock Medical Center • Aim: Symptom relief
Last updated Sep 02, 2026 00:00 UTC
-
Knee injection during surgery may ease arthritis pain
Symptom relief OngoingThis study tests whether an extended-release steroid injection (Zilretta) given during knee meniscus surgery can reduce pain and inflammation in people with osteoarthritis. 150 adults aged 40 and older are enrolled. Researchers will measure knee pain scores and inflammatory marke…
Phase 4 • Sponsor: The Cleveland Clinic • Aim: Symptom relief
Last updated Sep 02, 2026 00:00 UTC
-
A pocket coach for aching joints: can an app nudge osteoarthritis patients toward more activity?
Symptom relief OngoingThis study tests whether a smartphone app called PIANISSIMO can encourage people with osteoarthritis to be more physically active. Participants set weekly step goals and receive daily notifications about physical activity and its benefits for joint health. The trial focuses on wh…
Sponsor: Luxembourg Institute of Health • Aim: Symptom relief
Last updated Aug 27, 2026 00:00 UTC
-
App-Based therapy aims to tackle knee pain without pills
Symptom relief OngoingThis study tests whether a digital therapeutic called MORA Cure can reduce knee pain in adults over 50 with knee osteoarthritis and anterior knee pain. Participants use a mobile app for 8 weeks that provides personalized exercises and cognitive behavioral therapy content. The app…
Sponsor: EverEx Inc. • Aim: Symptom relief
Last updated Aug 20, 2026 00:00 UTC
-
Could prehab training during chemo strengthen young cancer patients?
Symptom relief OngoingThis study tests whether a supervised strength and balance exercise program is feasible for children and teens undergoing chemotherapy for bone or soft tissue sarcoma in the lower leg. The goal is to see if this 'prehabilitation' can reduce muscle and bone weakening, and improve …
Sponsor: Technical University of Munich • Aim: Symptom relief
Last updated Aug 20, 2026 00:00 UTC
-
Can a Mind-Body program ease knee pain and lift mood?
Symptom relief OngoingThis study tests whether a 10-week program called Positive Minds, Strong Joints is feasible for Black adults aged 50 and older with knee osteoarthritis. The program combines recommended exercise with mental health strategies to address pain, depression, and anxiety. Researchers w…
Sponsor: Boston University Charles River Campus • Aim: Symptom relief
Last updated Aug 13, 2026 00:00 UTC
-
New nerve block technique aims to cut opioid use after back surgery
Symptom relief By invitation onlyThis study tests whether a specific ultrasound-guided nerve block can reduce pain after elective lower back surgery better than the usual method of injecting pain medicine into the wound. Adults aged 18-65 undergoing surgery for conditions like a herniated disc or spinal stenosis…
Phase 4 • Sponsor: Engy Emil • Aim: Symptom relief
Last updated Aug 09, 2026 00:00 UTC
-
Can a lotion outperform standard gel for knee pain?
Symptom relief OngoingThis phase II trial is testing whether an experimental lotion called ASKC200 can reduce pain in people with knee osteoarthritis. About 175 adults aged 40 to 80 with knee pain lasting at least six months will be randomly assigned to receive one of two strengths of ASKC200, a stand…
Phase 2 • Sponsor: Jiangsu Aosaikang Pharmaceutical Co., Ltd. • Aim: Symptom relief
Last updated Aug 05, 2026 00:00 UTC
-
One-Shot knee injection could ease arthritis pain
Symptom relief OngoingThis study tests a single injection called 4P004 for people with knee osteoarthritis and synovitis (inflammation). About 129 adults aged 40-80 will receive either the injection or a placebo. The goal is to see if it reduces daily knee pain and improves function over 12 weeks.
Phase 2 • Sponsor: 4Moving Biotech • Aim: Symptom relief
Last updated Jul 29, 2026 00:00 UTC
-
New gel injection could ease arthritic knees
Symptom relief OngoingThis study tests a single injection of Hydrogel OA 2% in 20 adults with knee osteoarthritis. The goal is to see if the gel is safe and tolerable over 13 weeks to 12 months. Participants must be 35–75 years old with a BMI between 20 and 35.
Sponsor: Allegro NV/SA • Aim: Symptom relief
Last updated Jul 16, 2026 00:00 UTC
-
Could stem cells ease your aching back?
Symptom relief OngoingThis phase 2 study tests whether bone marrow stem cells can safely reduce pain in people with low back pain from worn-out facet joints. Forty participants will receive injections into the painful joints and be monitored for side effects and pain levels. The goal is to see if this…
Phase 2 • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Jul 08, 2026 00:00 UTC
-
Rare bone disease patient tries exercise therapy — early results promising?
Symptom relief OngoingThis study looks at whether a structured physiotherapy and exercise program can improve pain, strength, balance, and quality of life in one person with melorheostosis, a rare bone condition. The patient will do exercises three times a week for eight weeks, along with education ab…
Sponsor: Yeditepe University • Aim: Symptom relief
Last updated Jun 28, 2026 00:00 UTC
-
Robot vs robot: which knee surgery system wins?
Symptom relief By invitation onlyThis study compares two robotic-assisted systems (Velys J&J and Cori S&N) for total knee replacement in 200 people with severe knee arthritis. Researchers will measure knee alignment, movement, and patient-reported outcomes like pain and function. The goal is to see if one robot …
Sponsor: Jan Biziel University Hospital No 2 in Bydgoszcz • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
New knee shot aims to ease arthritis pain in early trial
Symptom relief By invitation onlyThis early-stage trial tests an experimental drug called RAB001, given as an injection into the knee joint, for people with knee osteoarthritis. The study includes 60 participants aged 40 to 75 who have persistent knee pain despite conservative treatments. Researchers are primari…
Phase 1 • Sponsor: ZhongShan LaiBo RuiChen BioMedicine Co.,Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Pain-blocking shot for kids' cleft palate surgery never tested
Symptom relief CancelledThis study planned to test whether a nerve block in the cheek area could reduce the need for morphine after cleft palate repair in children aged 5 months to 12 years. The experimental group would have received the nerve block, while the control group would not. However, the study…
Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Symptom relief
Last updated Jun 27, 2026 13:07 UTC
-
Pre-Surgery workouts may speed up joint replacement recovery
Symptom relief OngoingThis study tests whether a supervised exercise program before hip or knee replacement surgery can improve recovery, function, and quality of life. 44 adults with advanced osteoarthritis will do 3 weekly physiotherapy sessions plus daily home exercises for several weeks before the…
Sponsor: University of Jaén • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC
-
New hope for back pain sufferers: no surgery needed?
Symptom relief OngoingThis study looks at whether a non-surgical treatment called spinal decompression can help people with chronic low back pain. About 42 adults with back pain from disc problems or sciatica will receive the treatment over 12 weeks. Researchers will use MRI scans and movement tests t…
Sponsor: University of South Florida • Aim: Symptom relief
Last updated Jun 27, 2026 12:34 UTC
-
Knee replacement pain study: which injection works best?
Symptom relief By invitation onlyThis study compares two methods of giving the pain medicine EXPAREL during knee replacement surgery. About 40 adults will receive the medicine either as a targeted block or as local infiltration. Participants will report their pain levels and any extra pain medicines they need. T…
Phase 4 • Sponsor: Cedars-Sinai Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:34 UTC
-
Could one knee injection replace three? new trial tests simpler treatment
Symptom relief OngoingThis study compares a single large injection of hyaluronic acid to three smaller weekly injections for knee osteoarthritis. Researchers want to see if the one-shot approach is as safe and effective at reducing pain and improving knee function. The trial involves 46 adults aged 40…
Phase 2/3 • Sponsor: University of Erlangen-Nürnberg Medical School • Aim: Symptom relief
Last updated Jun 27, 2026 12:33 UTC
-
New nerve zapping technique could ease stubborn shoulder pain
Symptom relief OngoingThis study looks at whether a treatment called pulsed radiofrequency (PRF) applied to a key shoulder nerve can help people with long-lasting shoulder pain that hasn't improved with standard treatments like painkillers or physical therapy. The study involves 60 adults with chronic…
Sponsor: Gülçin Babaoğlu • Aim: Symptom relief
Last updated Jun 27, 2026 12:30 UTC
-
Can an online course keep arthritis patients working?
Symptom relief OngoingThis study tests an online program designed to help people with inflammatory arthritis remain employed. The program includes eLearning modules, group video sessions, and consultations with an occupational therapist and vocational counselor. About 528 participants from three Canad…
Sponsor: University of British Columbia • Aim: Symptom relief
Last updated Jun 27, 2026 12:28 UTC
-
Knee pain relief without pills? study tests exercise and Anti-Inflammatory diet
Symptom relief OngoingThis study tests whether a combination of a structured exercise program and a plant-based anti-inflammatory diet (the New Nordic Diet) can improve quality of life for people with mild to moderate knee osteoarthritis. Sixty participants will follow the training and diet plan, and …
Sponsor: St. Pölten University of Applied Sciences • Aim: Symptom relief
Last updated Jun 27, 2026 12:26 UTC
-
New study aims to cut opioid use after joint replacement
Symptom relief OngoingThis study tests whether adding ultrasound-guided nerve blocks before hip or knee replacement surgery can reduce pain and opioid use compared to standard pain management. 400 adults with osteoarthritis will be enrolled. The goal is to improve recovery and reduce side effects like…
Sponsor: Region Skane • Aim: Symptom relief
Last updated Jun 27, 2026 12:25 UTC
-
Can Ultrasound-Guided shots use less steroid for knee pain?
Symptom relief By invitation onlyThis study looks at whether a smaller dose of steroid injected into the knee with ultrasound guidance works as well as a larger dose given without ultrasound. The goal is to reduce side effects while still easing pain. About 140 people with knee osteoarthritis will receive one of…
Phase 4 • Sponsor: Sosi Dzhugarian • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Knee gel injection trial pulled before it began
Symptom relief CancelledThis study was designed to test whether a new gel called Hydrogel OA 2% could safely relieve knee osteoarthritis pain better than a standard treatment. It planned to enroll adults with knee OA and give them one injection, then track side effects and symptom improvement for 26 wee…
Sponsor: Allegro NV/SA • Aim: Symptom relief
Last updated Jun 27, 2026 12:06 UTC
-
Can exercise ease pain after radiation for bone cancer? small trial aims to find out
Symptom relief By invitation onlyThis study tests whether a structured, supervised exercise program is safe and feasible for people with painful non-spine bone metastases who have just had palliative radiotherapy. Twenty participants will follow an 8-week exercise plan plus a short maintenance period. Researcher…
Sponsor: University Health Network, Toronto • Aim: Symptom relief
Last updated Jun 27, 2026 12:06 UTC
-
Could a simple tourniquet change cut Post-Surgery pain and opioid use?
Symptom relief OngoingThis study tests whether using a lower-pressure tourniquet during orthopedic surgeries can reduce pain and the need for opioid painkillers afterward. Standard tourniquets use high pressure, which can cause muscle weakness and pain. The experimental device sets pressure based on t…
Sponsor: The Methodist Hospital Research Institute • Aim: Symptom relief
Last updated Jun 27, 2026 12:03 UTC
-
Vibration training may ease knee pain and boost mobility in seniors
Symptom relief By invitation onlyThis study looks at whether whole-body vibration training can improve body composition, muscle strength, walking speed, and pain in 30 older adults with knee osteoarthritis and sarcopenic obesity. Participants will do vibration exercises, and researchers will measure changes in p…
Sponsor: Beni-Suef University • Aim: Symptom relief
Last updated Jun 27, 2026 11:02 UTC
-
One shot could ease knee pain for a year: new hydrogel tested
Symptom relief OngoingThis study tests a single injection of Arthrosamid, a hydrogel made mostly of water, in 29 people with painful knee osteoarthritis. The goal is to see if it improves daily activity and reduces symptoms over 12 months. Participants wear an activity tracker to measure changes, and …
Sponsor: Medisch Centrum Latem • Aim: Symptom relief
Last updated Jun 27, 2026 11:01 UTC
-
New sound tricks could help cochlear implant users hear better in noise
Symptom relief OngoingThis study tests experimental sound coding strategies that may improve hearing for adult cochlear implant users. About 120 participants will compare the new strategies to their current settings, focusing on understanding speech in noisy environments. The goal is to find ways to m…
Sponsor: Cochlear • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
Robot-Assisted knee surgery: better results for arthritis patients?
Symptom relief OngoingThis study compares robotic-assisted knee replacement to the traditional manual method in 100 people with severe knee arthritis. The goal is to see which approach leads to better knee alignment, movement, and patient satisfaction. Participants are randomly assigned to one of the …
Sponsor: Jakub Błaszczyk • Aim: Symptom relief
Last updated Jun 27, 2026 09:11 UTC
-
New combo treatment aims to quiet jaw pain for TMD sufferers
Symptom relief OngoingThis study tests whether wearing a custom mouth splint and getting a granisetron injection into the jaw muscle reduces pain from temporomandibular disorders (TMD) better than the splint alone or with lidocaine. About 48 adults with jaw muscle pain will be followed for 6 months. T…
Phase 4 • Sponsor: Mansoura University • Aim: Symptom relief
Last updated Jun 27, 2026 09:10 UTC
-
Sound waves vs. bone pain: can ultrasound replace radiation?
Symptom relief OngoingThis study tests whether MR-guided focused ultrasound (MR-HIFU), alone or with standard radiotherapy, can better relieve pain from bone metastases than radiotherapy alone. About 216 adults with painful bone lesions will be randomly assigned to one of three groups. The goal is to …
Sponsor: UMC Utrecht • Aim: Symptom relief
Last updated Jun 27, 2026 09:10 UTC
-
Knee pain relief: supplement and exercise combo tested
Symptom relief OngoingThis study looks at whether adding a dietary supplement to an exercise program can reduce pain and improve movement in people with knee osteoarthritis. About 93 adults with mild to moderate knee arthritis will be split into three groups: supplement alone, supplement plus exercise…
Sponsor: University of Primorska • Aim: Symptom relief
Last updated Jun 27, 2026 09:08 UTC
-
Laser heat therapy could ease knee pain without smoke
Symptom relief OngoingThis study tests whether adding a special laser treatment (CO2 infrared laser moxibustion) to standard exercise can reduce knee pain and improve movement in people with knee osteoarthritis. About 68 adults aged 55-65 with knee arthritis will receive either exercise alone or exerc…
Sponsor: University of Lahore • Aim: Symptom relief
Last updated Jun 27, 2026 09:06 UTC
-
Heat therapy for knee pain: new study tests Nerve-Burning procedure after failed replacements
Symptom relief OngoingThis study tests whether a procedure called genicular radiofrequency ablation can safely reduce persistent knee pain in people who still hurt more than a year after total knee replacement. The procedure uses heat to temporarily calm specific nerves around the knee. Half of the 44…
Sponsor: University of Calgary • Aim: Symptom relief
Last updated Jun 27, 2026 09:02 UTC
-
Knee replacement patients may need fewer steroid doses for better recovery
Symptom relief By invitation onlyThis study compares giving one dose of dexamethasone during knee replacement surgery versus two doses (one during surgery and one the next morning). The goal is to see which approach reduces pain, opioid use, and nausea while minimizing complications. About 339 adults undergoing …
Phase 4 • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Jun 27, 2026 09:02 UTC
-
Zapping away joint pain? new study tests Low-Dose radiation for osteoarthritis
Symptom relief OngoingThis study follows 40 adults aged 55+ with osteoarthritis who are getting low-dose radiation as part of their usual care. Researchers will track pain, function, and quality of life for up to a year to see if the treatment helps. The goal is to understand how well this approach wo…
Sponsor: University of North Carolina, Chapel Hill • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
Pre-surgery pain class may ease joint replacement recovery
Symptom relief By invitation onlyThis study tests whether giving patients a pain education booklet and video before knee or hip replacement surgery helps them feel less anxious and have less pain afterward. About 70 adults scheduled for elective joint replacement will be randomly assigned to receive the educatio…
Sponsor: Yeditepe University • Aim: Symptom relief
Last updated Jun 27, 2026 08:13 UTC
-
VR games could replace traditional physio for knee pain
Symptom relief OngoingThis study tests whether a home-based virtual reality system can help people with knee osteoarthritis do their physiotherapy exercises in a more engaging way. Fifty adults aged 45 and older with knee pain will be randomly assigned to either the VR program or standard physiotherap…
Sponsor: Cardiff University • Aim: Symptom relief
Last updated Jun 27, 2026 08:12 UTC
-
Jaw surgery showdown: which TMJ fix works best?
Symptom relief By invitation onlyThis study looks back at 65 adults who had one of two surgeries for a painful jaw joint condition (TMJ disc displacement). The goal is to see which surgery better improves mouth opening, reduces pain, and helps the jaw work better. Researchers also check recovery speed, side effe…
Sponsor: Karolinska Institutet • Aim: Symptom relief
Last updated Jun 27, 2026 08:07 UTC
-
Exercise as medicine? new study tests High-Intensity workouts for rheumatoid arthritis
Symptom relief OngoingThis study looks at whether a 12-week program of high-intensity interval exercise can improve heart function, reduce inflammation, and boost quality of life in people with rheumatoid arthritis. 87 adults with stable, low-to-moderate disease activity will take part. The program in…
Sponsor: Vastra Gotaland Region • Aim: Symptom relief
Last updated Jun 27, 2026 08:06 UTC
-
RA injection study pulled before it even started
Symptom relief CancelledThis study aimed to test the safety of a new drug called F8IL10, given as a joint injection every 4 weeks for 8 weeks, in people with rheumatoid arthritis who still have joint flares despite standard treatments. The goal was to find the safest dose. However, the study was withdra…
Phase 1 • Sponsor: Philogen S.p.A. • Aim: Symptom relief
Last updated Jun 27, 2026 08:01 UTC
-
High-Tech GPS for your knee: new navigation system aims to improve joint replacement
Symptom relief OngoingThis study is testing a new computer-assisted navigation system for total knee replacement surgery in 126 adults with knee arthritis. The system helps surgeons place the artificial joint more accurately. Researchers will measure how well patients can use their knee 3 and 12 month…
Sponsor: GCS Ramsay Santé pour l'Enseignement et la Recherche • Aim: Symptom relief
Last updated Jun 27, 2026 08:01 UTC
-
Knee replacement patients get a push to move more
Symptom relief OngoingThis study tests whether phone coaching and financial rewards can help people become more active after total knee replacement. 600 adults aged 40-85 will be split into three groups: usual care, activity tracker only, or activity tracker plus coaching and rewards. The goal is to s…
Sponsor: Brigham and Women's Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 07:59 UTC
-
Can laser beams ease your aching knees?
Symptom relief OngoingThis study tests whether adding laser therapy to standard physiotherapy and exercise reduces knee osteoarthritis pain more than a sham (fake) laser plus exercise. Sixty-four adults with knee osteoarthritis will receive either real or sham laser treatments twice a week for six wee…
Sponsor: DJO UK Ltd • Aim: Symptom relief
Last updated Jun 27, 2026 07:58 UTC
-
Botox vs steroids for knee pain: study pulled before starting
Symptom relief CancelledThis study was designed to see if a Botox injection into the knee joint could relieve arthritis pain better than a steroid injection. Researchers planned to use special MRI scans to measure inflammation. However, the trial was withdrawn before enrolling any participants, so no re…
Phase 2 • Sponsor: Lille Catholic University • Aim: Symptom relief
Last updated Jun 26, 2026 16:30 UTC
-
Kids' scoliosis study tracks movement and muscle changes
Knowledge-focused By invitation onlyThis study follows 200 children aged 9-16 with scoliosis to see how spinal fusion surgery or bracing affects their muscle function and daily activity. Participants wear activity monitors and undergo muscle stiffness tests at the start and one year later. The goal is to learn more…
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Brain scans reveal secrets of lost smell
Knowledge-focused By invitation onlyThis study tracks 80 adults with different smell disorders (like total loss, partial loss, or distorted smell) plus healthy volunteers over one year. Researchers use brain scans, smell tests, and questionnaires to see how the brain changes and how smell loss impacts mood and dail…
Sponsor: National Institute on Deafness and Other Communication Disorders (NIDCD) • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Scientists track families to uncover Cancer's hidden causes
Knowledge-focused OngoingThis study looks at people and families who have a high risk of cancer to learn what genes and environmental factors might increase that risk. Over 5,000 participants are followed over time with questionnaires, medical records, and optional genetic testing. No treatment is given,…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Rare bone cancer study hunts for hidden genetic triggers
Knowledge-focused OngoingThis study aims to find genetic changes that may cause sporadic chordoma, a rare bone cancer. Researchers will collect saliva and medical records from 188 patients across the U.S. and Canada who are the only ones in their family with chordoma. No treatment is given; the goal is t…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Can shedding pounds reshape the legs? a study tracks joint alignment after Weight-Loss surgery
Knowledge-focused OngoingThis observational study follows adults with morbid obesity who undergo bariatric surgery to see if substantial weight loss changes the alignment of their hips, knees, and ankles. Researchers measure leg alignment using standing X-rays before surgery and at 3, 6, and 12 months af…
Sponsor: Marmara University • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
New brain scan may predict chemo brain in young leukemia patients
Knowledge-focused PausedThis study tests a quick, non-invasive brain scan called Magnetic Resonance Fingerprinting (MRF) in children and young adults with acute leukemia. The goal is to see if the scan can detect early brain changes caused by chemotherapy. Participants also take a fun, game-like memory …
Sponsor: Case Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Sep 17, 2026 00:00 UTC
-
2000 volunteers needed to test Next-Gen MRI scans
Knowledge-focused OngoingThis study aims to test new MRI sequences in 2000 adults (patients and healthy volunteers) to see if they can produce better images than current methods. Participants will undergo additional scans during their regular MRI. The goal is to improve diagnostic capabilities without di…
Phase 4 • Sponsor: Northwestern University • Aim: Knowledge-focused
Last updated Sep 17, 2026 00:00 UTC
-
Sound waves may replace X-Rays for dental implant timing
Knowledge-focused OngoingThis study at the University of Michigan is testing whether ultrasound can monitor bone graft healing after tooth extraction, potentially replacing more invasive scans. About 140 adults needing a tooth extraction and bone graft for a future dental implant will have their healing …
Sponsor: University of Michigan • Aim: Knowledge-focused
Last updated Sep 16, 2026 00:00 UTC
-
Dialysis showdown: which method protects heart and bones best?
Knowledge-focused OngoingThis study looks at how different types of dialysis affect heart health, bone metabolism, inflammation, and quality of life in people with end-stage kidney disease. Researchers will compare patients on hemodialysis, continuous ambulatory peritoneal dialysis, and automated periton…
Sponsor: Gazi University • Aim: Knowledge-focused
Last updated Sep 16, 2026 00:00 UTC
-
AI chatbot aims to ease tough choices for osteoarthritis patients
Knowledge-focused OngoingThis study tests whether an AI chatbot can help people with hip or knee osteoarthritis feel less conflicted and anxious about their treatment choices. About 100 adults with osteoarthritis will chat with the AI before seeing their surgeon. Researchers will measure changes in decis…
Sponsor: University of California, Davis • Aim: Knowledge-focused
Last updated Sep 16, 2026 00:00 UTC
-
New scan could improve how we monitor bone metastases in breast cancer
Knowledge-focused OngoingThis phase 2 trial is testing whether a special type of PET/CT scan (FDG-PET/CT) can better measure how breast cancer that has spread to the bones responds to treatment. The study involves 138 participants with hormone receptor-positive metastatic breast cancer that is mostly in …
Phase 2 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Knowledge-focused
Last updated Sep 16, 2026 00:00 UTC
-
New cage for neck surgery under observation – no treatment given
Knowledge-focused OngoingThis study watches 24 adults who are getting standard neck fusion surgery with a special device called the BEE HA cage. The goal is to see how well the cage helps with pain and function over time. No new treatment is tested—just careful tracking of normal surgery results.
Sponsor: Invibio Ltd • Aim: Knowledge-focused
Last updated Sep 11, 2026 00:00 UTC
-
New tool measures how knee surgery affects emotional health
Knowledge-focused OngoingThis study aims to validate a new questionnaire that measures emotional wellbeing and patient perceptions after total knee replacement surgery for knee arthritis. Researchers will enroll 167 adults who had knee replacement within the last 3 months. The goal is to ensure the quest…
Sponsor: Invibio Ltd • Aim: Knowledge-focused
Last updated Sep 11, 2026 00:00 UTC
-
PRP knee injections: new study looks at blood protein changes in osteoarthritis patients
Knowledge-focused OngoingThis study tests whether platelet-rich plasma (PRP) injections into the knee can change certain proteins in the blood of people with knee osteoarthritis. About 60 participants aged 18-70 will receive either PRP or a saltwater placebo, and researchers will compare protein levels t…
Phase 2 • Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Sep 10, 2026 00:00 UTC
-
Choice or fixed? study tests how to get better data from young cancer patients
Knowledge-focused OngoingThis study enrolls 400 adolescents and young adults (ages 18-39) recently diagnosed with various cancers. Participants are randomly assigned to either choose which health-related questions they answer or receive a fixed set of questions. The goal is to see if giving patients a ch…
Early phase 1 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Knowledge-focused
Last updated Sep 06, 2026 00:00 UTC
-
New blood test could spot cancer return after transplant
Knowledge-focused OngoingThis study is testing a new blood test called AlloHeme that measures how much of a patient's own cells remain after a bone marrow transplant. The goal is to see if this test can predict whether the cancer (acute leukemia or myelodysplastic syndrome) will come back. About 307 adul…
Sponsor: CareDx • Aim: Knowledge-focused
Last updated Sep 05, 2026 00:00 UTC
-
Shoulder implant safety tracked for years after surgery
Knowledge-focused OngoingThis study follows 76 people who received a pyrocarbon shoulder implant to see how well it works and holds up over 5 to 10 years. Researchers measure shoulder pain, function, and any complications. The goal is to confirm the implant is safe and effective for long-term use.
Sponsor: Stryker Trauma and Extremities • Aim: Knowledge-focused
Last updated Sep 03, 2026 00:00 UTC
-
Massive medicare study aims to improve joint replacement safety
Knowledge-focused OngoingThis study looks at records from over 500,000 Medicare beneficiaries with rheumatoid arthritis or ankylosing spondylitis who had major orthopedic procedures like joint replacements or spine surgery between 1999 and 2015. Researchers want to understand how often complications happ…
Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) • Aim: Knowledge-focused
Last updated Sep 03, 2026 00:00 UTC
-
Can knee cartilage reveal why osteoarthritis worsens?
Knowledge-focused By invitation onlyThis study examines cartilage from people undergoing total knee replacement for osteoarthritis. Researchers will use a microscope to look at cell health, mitochondria, and autophagosomes, which are parts of cells involved in cleaning up damage. The goal is to better understand ho…
Sponsor: Yunnan University of Chinese Medicine • Aim: Knowledge-focused
Last updated Sep 03, 2026 00:00 UTC
-
Will a new drug form work the same? study tests two versions of SKI-O-703
Knowledge-focused OngoingThis study tests whether two different capsule forms of the experimental drug SKI-O-703 are absorbed similarly in the body. About 48 healthy adults (Korean and Caucasian) will take a single dose of each form on separate days, with blood samples taken to compare drug levels. The r…
Phase 1 • Sponsor: Oscotec Inc. • Aim: Knowledge-focused
Last updated Sep 03, 2026 00:00 UTC
-
New hip stem under the microscope: will it last?
Knowledge-focused OngoingThis study looks at how well a new hip replacement stem (Insignia) fits and stays in place over time. Researchers will review X-rays from 100 adults getting a first-time hip replacement to check for any signs of loosening. The goal is to see if the stem is safe and effective for …
Sponsor: University of Utah • Aim: Knowledge-focused
Last updated Sep 03, 2026 00:00 UTC
-
New study aims to unlock XLH mysteries in adults
Knowledge-focused CancelledThis study will follow 100 adults with X-linked hypophosphatemia (XLH) who are already taking burosumab. Researchers want to see how phosphate levels change over time and how they relate to bone health and overall disease burden. The goal is to better understand the condition and…
Sponsor: Novo Nordisk A/S • Aim: Knowledge-focused
Last updated Aug 30, 2026 00:00 UTC
-
Massive psoriasis registry tracks drug safety over years
Knowledge-focused OngoingThis study is a large registry that follows nearly 16,000 people with psoriasis to monitor the long-term safety of several treatments, including biologic drugs like infliximab and ustekinumab. Participants receive their usual care while researchers track side effects, disease act…
Sponsor: Janssen Scientific Affairs, LLC • Aim: Knowledge-focused
Last updated Aug 30, 2026 00:00 UTC
-
Can 3D-printed guides tame the toughest spine screws?
Knowledge-focused OngoingResearchers are reviewing past spinal fusion surgeries to see if patient-specific guides, called MySpine, place screws safely even in the most challenging bone. They will compare nerve irritation rates between standard screws and those in anatomically complex positions, known as …
Sponsor: I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio • Aim: Knowledge-focused
Last updated Aug 29, 2026 00:00 UTC
-
10 years after ACL surgery: researchers use MRI to peek inside knees for early arthritis clues
Knowledge-focused By invitation onlyThis study looks at 219 people who had ACL reconstruction surgery about 10 years ago. Researchers will use MRI scans to check the health of the knee cartilage and compare it to the uninjured knee. The goal is to learn more about how osteoarthritis develops after a knee injury.
Sponsor: The Cleveland Clinic • Aim: Knowledge-focused
Last updated Aug 26, 2026 00:00 UTC
-
New study tests if teaching women about bone health can prevent osteoporosis
Knowledge-focused By invitation onlyThis study aims to see if a structured education program based on the Health Belief Model can improve osteoporosis awareness and health beliefs in women aged 45 and older who have at least one risk factor for the disease. About 74 women will be randomly assigned to either receive…
Sponsor: Bartın Unıversity • Aim: Knowledge-focused
Last updated Aug 22, 2026 00:00 UTC
-
Can young sarcoma survivors fully recover? a new study investigates
Knowledge-focused OngoingThis study looks at children, teens, and young adults who finished treatment for bone or soft tissue sarcoma in the lower leg or thigh 1 to 5 years ago. It measures muscle size, body composition, strength, mobility, and quality of life to see if they have lasting physical limitat…
Sponsor: Technical University of Munich • Aim: Knowledge-focused
Last updated Aug 20, 2026 00:00 UTC
-
Scoliosis's hidden toll: can we predict lung and heart risks?
Knowledge-focused OngoingThis study looks back at 10 years of medical records from a scoliosis referral center to see how frequently adults with scoliosis who had surgery also develop restrictive breathing problems or signs of pulmonary hypertension on echocardiography. By analyzing data from 174 patient…
Sponsor: Poitiers University Hospital • Aim: Knowledge-focused
Last updated Aug 14, 2026 00:00 UTC
-
Can a biologic drug tame juvenile arthritis in kids?
Knowledge-focused CancelledThis study follows children aged 6 to 17 with active juvenile enthesitis-related or psoriatic arthritis who are being treated with secukinumab. Researchers will track how long children stay on the drug, how much their symptoms improve, and whether they achieve remission. The goal…
Sponsor: Novartis Pharmaceuticals • Aim: Knowledge-focused
Last updated Aug 09, 2026 00:00 UTC
-
Simple tests could revolutionize chronic pain diagnosis
Knowledge-focused OngoingThis study aims to improve how doctors diagnose and treat chronic muscle and joint pain by using simple questionnaires and pain sensitivity tests. Researchers will study 250 adults with conditions like osteoarthritis, fibromyalgia, chronic low back pain, or inflammatory arthritis…
Sponsor: University of Nottingham • Aim: Knowledge-focused
Last updated Jul 17, 2026 00:00 UTC
-
Digital diary aims to decode painful flares in spine condition
Knowledge-focused OngoingThis study investigates how people with axial spondyloarthritis (axSpA) experience sudden worsening of symptoms, known as flares. Over 12 months, 40 participants use a digital diary to track symptoms, diet, lifestyle, and self-management strategies, and provide blood samples duri…
Sponsor: Royal United Hospitals Bath NHS Foundation Trust • Aim: Knowledge-focused
Last updated Jul 09, 2026 00:00 UTC
-
New study aims to predict Paget's disease before it strikes
Knowledge-focused OngoingThis study looks at whether a genetic test can predict who will develop Paget's disease of the bone, a condition that can cause pain, deformity, and hearing loss. Researchers are studying 135 people aged 45 and older who have a parent or sibling with Paget's but do not have the d…
Sponsor: University of Edinburgh • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Math formula could help surgeons cut bone graft waste in tumor surgery
Knowledge-focused OngoingThis study tests whether a simple mathematical formula, applied to routine CT scans, can accurately predict the size of a bone defect that will be created during surgery to remove a bone tumor. Accurate prediction could help surgeons select the right-sized donor bone graft before…
Sponsor: Sakarya University • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Cushing's disease study in western france withdrawn before starting
Knowledge-focused CancelledThis study was designed to look back at the health of people with Cushing's disease in Western France between 1990 and 2015. The goal was to find out how many patients went into remission and how many had their disease come back after their first surgery. However, the study was w…
Sponsor: University Hospital, Brest • Aim: Knowledge-focused
Last updated Jun 28, 2026 00:00 UTC
-
Do blood transfusions help at the end of life? a study asks patients and staff
Knowledge-focused OngoingThis study looks at how patients with advanced blood cancers (like acute myeloid leukemia) who are not eligible for a cure, along with their nurses and doctors, feel about the benefits of blood transfusions. Researchers will give questionnaires before each transfusion to compare …
Sponsor: University Hospital, Montpellier • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
Study aims to see if patient diaries match insurance data
Knowledge-focused CancelledThis study was designed to see how accurately patients report their own medication and healthcare use in diaries compared to official health insurance records. It planned to include people with diabetes, arthritis, kidney disease, or prostate cancer. However, the study was withdr…
Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Knee X-Ray study pulled before starting
Knowledge-focused CancelledThis study was designed to see if X-rays taken before knee replacement surgery could reliably show ligament damage in people with knee arthritis. It was an observational study, meaning no treatment was given. However, the study was withdrawn before enrolling any participants, so …
Sponsor: Rennes University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
Knee replacement recovery study pulled before it began
Knowledge-focused CancelledThis study aimed to test different regional anesthesia techniques to help people recover faster and go home sooner after total knee replacement. It planned to compare a standard pain injection with an added nerve block or continuous nerve block infusion. However, the study was wi…
Phase 4 • Sponsor: McMaster University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:03 UTC
-
New study to track severe joint infections in ICU patients
Knowledge-focused PausedThis study looks at patients in intensive care who have an infection in a joint replacement (like a hip or knee). Researchers want to understand their care path, recovery, and survival over two years. The study will collect data from medical records and phone calls with patients …
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
New study tracks how leukemia drug works outside the lab
Knowledge-focused OngoingThis study follows 201 adults with chronic myeloid leukemia who are taking asciminib (Scemblix) as a third or later treatment option. Researchers want to see how long patients stay on the drug and how well it controls their cancer in real-world settings. The goal is to gather pra…
Sponsor: Novartis Pharmaceuticals • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
New study aims to stop knee implants from failing in obese women
Knowledge-focused OngoingThis study looks at 54 obese women getting knee replacements to see if a stemmed or non-stemmed tibial implant works better. The goal is to find out which type reduces the risk of the implant collapsing or loosening over time. Researchers will track these outcomes to guide future…
Sponsor: Jacob M. Elkins • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Brain scans may predict who gets long-term pain from arthritis
Knowledge-focused OngoingThis study looks at why some people with early rheumatoid arthritis develop long-lasting chronic pain while others do not. Researchers will use pain sensitivity tests and brain scans to find clues. The goal is to better understand the transition from acute to chronic pain, which …
Sponsor: Northwestern University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:38 UTC
-
Withdrawn study sought to understand sinus problems in young cancer survivors
Knowledge-focused CancelledThis study aimed to find out how often chronic sinusitis occurs in children treated for head and neck cancer, and how it affects their quality of life. Researchers planned to compare these children to those treated for cancer elsewhere in the body using a questionnaire called SNO…
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Fitness check may guide better leukemia care for seniors
Knowledge-focused OngoingThis study looks back at medical records of 725 older adults (over 65) with acute myeloid leukemia (AML). Researchers want to see if using a special 'fitness' score to choose treatment leads to longer survival. No new treatments are given; the goal is to learn which treatment app…
Sponsor: Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC
-
Bone metastasis database study aims to improve patient quality of life
Knowledge-focused CancelledThis study collects medical information from patients whose cancer has spread to the bone. The goal is to learn more about how cancer affects bones and how to prevent complications like fractures and pain. No extra tests or visits are needed—just data from regular care. The study…
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:34 UTC
-
Does an extra knee ligament procedure lead to arthritis later?
Knowledge-focused By invitation onlyThis study follows 510 people who had ACL knee reconstruction surgery, with or without an extra procedure called LET, about 10 years ago. Researchers want to see if adding LET increases the chance of developing knee osteoarthritis. Participants will get X-rays and answer question…
Sponsor: Western University, Canada • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:34 UTC
-
Hip surgery patients tracked for sports comeback
Knowledge-focused By invitation onlyThis study follows 26 people who had hip surgery (periacetabular osteotomy) for hip dysplasia. Researchers want to see how many return to their favorite sports and how well they recover. The study collects data from medical records and patient reports, focusing on pain levels and…
Sponsor: Istituto Ortopedico Rizzoli • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:33 UTC
-
Massive hip replacement study seeks best stem length
Knowledge-focused By invitation onlyThis study looks at over 110,000 people who had hip replacement surgery to see if a longer or shorter hip stem works better. It compares death rates, how often the hip implant needs to be replaced, and patient-reported pain and function. The goal is to find out which stem length …
Sponsor: JointResearch • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
Massive UK study tracks 12,000 women and their children for 20 years to unlock secrets of lifelong health
Knowledge-focused OngoingThis long-term study recruited over 12,000 non-pregnant women in Southampton, UK, and followed about 3,000 of them through pregnancy and their children's growth up to age 19. Researchers are tracking body composition, nutrition, asthma, and heart health to understand how a mother…
Sponsor: University of Southampton • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:31 UTC
-
Tiny study peers inside finger joints to unlock RA bone erosion secrets
Knowledge-focused OngoingThis study looks at bone erosions in the finger joints of 9 people with rheumatoid arthritis. Researchers use advanced imaging and tissue analysis to see tiny blood vessels and bone structure. The goal is to better understand how joint damage happens, which could lead to better m…
Sponsor: University of Aarhus • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Knee replacement showdown canceled before it started
Knowledge-focused CancelledThis study aimed to compare knee movement in people who had one of two different total knee replacements. Researchers planned to measure how the knee bends and shifts during activities like stepping up and deep knee bends. The study was withdrawn before any participants were enro…
Sponsor: The University of Tennessee, Knoxville • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
450 babies help scientists unlock secrets of healthy eating
Knowledge-focused OngoingThis study follows 450 infants and their families from birth to age 12 to learn how a child's biology and home environment work together to shape eating habits and growth. Researchers collect samples, measurements, and surveys at regular visits. The goal is to understand what inf…
Sponsor: University of Illinois at Urbana-Champaign • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC
-
Spine surgery showdown: robot vs. Surgeon's hand
Knowledge-focused OngoingThis study compares robot-assisted spine surgery to the traditional method in 300 adults needing spinal fusion. The goal is to see if the robot helps place screws more accurately, reduces complications, and improves patient outcomes. Participants are randomly assigned to either r…
Sponsor: Elsan • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Hip implant under the microscope: 5-Year safety study launched
Knowledge-focused OngoingThis study is tracking 120 people who received a HYPE SCS hip stem during total hip replacement. Researchers will monitor how long the implant lasts, how satisfied patients are, and any complications over 5 years. The goal is to confirm the device is safe and works as intended in…
Sponsor: Societe dEtude, de Recherche et de Fabrication • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Massive study of 190,000 workers to uncover hidden radiation risks
Knowledge-focused OngoingThis study follows about 190,000 Korean radiation workers to see if low-dose radiation exposure over time increases the risk of cancer and other diseases. Researchers will link national health records to track health outcomes. The goal is to better understand the long-term effect…
Sponsor: Korea Institute of Radiological & Medical Sciences • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:09 UTC
-
New study digs into how mepolizumab changes nose bacteria and genes in asthma patients
Knowledge-focused OngoingThis study tracks 40 people with nasal polyps and severe asthma who are taking mepolizumab, a drug that reduces inflammation. Researchers collect nose, blood, and sputum samples before treatment and at 3, 6, and 12 months to see how the drug affects symptoms, nose bacteria, and g…
Sponsor: National and Kapodistrian University of Athens • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC
-
Could your phone camera replace blood tests? new study explores
Knowledge-focused OngoingThis study follows 60 people with lower-risk myelodysplastic neoplasms (MDS) who need regular red blood cell transfusions. Over 6 months, participants use a smartphone app to answer weekly quality-of-life questions and take photos of their fingernails or eyelids. Researchers aim …
Sponsor: University of Leipzig • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC
-
Could a simple quiz replace bone scans for osteoporosis in men?
Knowledge-focused OngoingThis study checks whether two easy-to-use risk calculators (OST and MORES) can accurately predict osteoporosis in Turkish men aged 50-75, compared to the standard DEXA bone density scan. Researchers will enroll 140 men to see how sensitive and specific these tools are. If they wo…
Sponsor: Kayseri City Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC
-
New study observes patients getting nasal stem cell therapy for brain conditions
Knowledge-focused By invitation onlyThis observational study follows 36 people with neurologic conditions like traumatic brain injury, cerebral palsy, multiple sclerosis, or Alzheimer's who are already receiving intranasal MuSE stem cell or exosome therapy as part of their routine care. Researchers track safety and…
Sponsor: Healing Hope International • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC
-
Blood test may predict Steroid-Induced bone loss
Knowledge-focused OngoingThis study looks for a biomarker to identify people at risk of bone loss from glucocorticoid medications like prednisolone. 36 healthy volunteers will take either prednisolone or a placebo for seven days. Researchers will measure bone turnover markers in blood and collect bone, m…
Phase 2 • Sponsor: Odense University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:04 UTC
-
New computer model aims to predict fractures in rare bone disorder patients
Knowledge-focused OngoingThis study is testing whether a computer tool called MEKANOS can better predict the risk of hip fractures in people with Fibrous Dysplasia or McCune-Albright Syndrome. Researchers will take CT scans of the femur and use the tool to calculate bone strength. The goal is to improve …
Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:03 UTC
-
Spine surgery showdown: robot vs. human hand – which is safer?
Knowledge-focused OngoingThis study looks at three ways surgeons place screws in the spine during surgery: using a robot, using a navigation system, or doing it by hand. The goal is to see which method leads to fewer screws needing to be fixed in a second surgery within the first year. About 932 adults w…
Sponsor: Marc Schröder • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:02 UTC
-
Spine curve study: surgery vs. no surgery – which works better?
Knowledge-focused OngoingThis study follows nearly 2,000 adults with spinal deformity (curved spine) to compare outcomes between those who have surgery and those who do not. Researchers track X-rays, pain levels, and quality of life over time. The goal is to learn which approach leads to better long-term…
Sponsor: International Spine Study Group Foundation • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
Rare disease pregnancy study pulled before it began
Knowledge-focused CancelledThis study was designed to track pregnancies in women with rare autoimmune and systemic diseases to understand complications and improve care. It planned to enroll women with conditions like lupus, rheumatoid arthritis, and scleroderma. However, the study was withdrawn before any…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
Massive study aims to curb unnecessary antibiotics in kids
Knowledge-focused OngoingThis project works to make sure children with common respiratory infections get the right antibiotics for the right amount of time. It involves over 259,000 kids across many clinics. The goal is to learn the best ways to help doctors follow antibiotic guidelines and reduce unnece…
Sponsor: Intermountain Health Care, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
CAR-T therapy patients monitored for years in new safety study
Knowledge-focused By invitation onlyThis study follows 178 patients who previously received an AvenCell CAR-T cell therapy for cancers like lymphoma, leukemia, or prostate cancer. Researchers will track delayed side effects, including new cancers or autoimmune issues, for years. No new treatment is given—this is pu…
Sponsor: AvenCell Therapeutics, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC
-
Which expander works best for cleft kids? new trial aims to find out
Knowledge-focused OngoingThis study compares two dental devices—the quadhelix and mini-hyrax expanders—in 24 children with cleft lip and palate who need their upper jaw widened before bone graft surgery. Researchers will use 3D scans and models to measure how much the jaw expands. The goal is to see whic…
Sponsor: Cairo University • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC
-
Can a simple conversation tool boost surgery satisfaction for arthritis patients?
Knowledge-focused OngoingThis study looks at whether using a patient decision aid during doctor visits helps people with severe hip or knee osteoarthritis make better choices about surgery. Researchers will track how informed patients feel, their involvement in decisions, and their pain, function, and qu…
Sponsor: Vejle Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC
-
New questionnaire for spinal stenosis patients never gets off the ground
Knowledge-focused CancelledThis study aimed to create and test a new questionnaire to better measure how lumbar spinal stenosis limits daily activities. It planned to enroll adults aged 50 and older with the condition, who would fill out several online surveys. However, the study was withdrawn before any p…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC
-
15-Year safety check for caribou cell therapy patients
Knowledge-focused By invitation onlyThis study follows about 150 people who previously received Caribou cell therapy for blood cancers like lymphoma or leukemia. Researchers will check for long-term side effects and overall survival for up to 15 years after treatment. No new treatment is given—this is just observat…
Sponsor: Caribou Biosciences, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC
-
Study on COVID-19 and blood cancer connection pulled before starting
Knowledge-focused CancelledThis study was designed to learn how the protein calprotectin might change blood stem cells in people with severe COVID-19 or certain blood cancers. Researchers planned to compare cells from patients and healthy donors in the lab. However, the study was withdrawn before any parti…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC
-
Knee replacement showdown: which design lets you move best?
Knowledge-focused OngoingThis study looks at three different knee replacement designs: one that keeps the ACL, one that substitutes for it, and one that sacrifices it. Researchers want to see which design gives the best function, pain relief, and satisfaction in 75 people with severe knee arthritis. Part…
Sponsor: Universitaire Ziekenhuizen KU Leuven • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC
-
Knee replacement patients: what really gets you back to work?
Knowledge-focused OngoingThis study follows 88 working-age adults (63 or younger) who had knee replacement surgery to see when and how many return to work. Researchers track pain, knee function, and work ability using questionnaires over 1.5 years. The goal is to identify factors that help or hinder retu…
Sponsor: Universitaire Ziekenhuizen KU Leuven • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC
-
Fatty liver and psoriasis study pulled before it started
Knowledge-focused CancelledThis study aimed to understand the link between non-alcoholic fatty liver disease (NAFLD) and psoriatic disease (psoriasis and psoriatic arthritis) in overweight adults. Researchers planned to use the drug guselkumab (Tremfya) to see if it improved both conditions. However, the t…
Sponsor: University of California, San Diego • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:07 UTC
-
New hip implant under the microscope: will it last 10 years?
Knowledge-focused OngoingThis study follows 125 adults aged 18-75 who are getting a hip replacement with a new type of implant (the Trident II shell). The main goal is to see how long the implant lasts without needing another surgery. Researchers will also track patients' pain and function using a standa…
Sponsor: NHS Lothian • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC
-
Scientists hunt for hidden genes behind aortic aneurysms
Knowledge-focused OngoingThis study aims to uncover the genetic roots of aortic aneurysms and valve disease by analyzing tissue and blood samples from 3,000 participants. Researchers will look for new disease-causing genes and factors that affect disease severity. The goal is to build a biorepository to …
Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:04 UTC
-
Sinus study pulled before it even started
Knowledge-focused CancelledThis study was designed to see how chronic sinusitis affects the tiny hair-like cells (cilia) that help clear mucus from the nose. Researchers planned to use special glowing nano-sticks to measure how well these cells work. However, the study was withdrawn before any participants…
Sponsor: Centre Hospitalier Intercommunal Creteil • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:04 UTC
-
Joint infection study pulled before starting: antibiotic duration question remains unanswered
Knowledge-focused CancelledThis study aimed to find the best length of time for patients to take antibiotics after surgery for an infected joint replacement. It planned to compare different antibiotic durations to see which works best to prevent the infection from coming back and to avoid antibiotic resist…
Sponsor: University of Maryland, Baltimore • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC
-
Teen scoliosis study aims to unlock secrets of spine movement and balance
Knowledge-focused By invitation onlyThis study looks at how the way the lower back and pelvis move together (lumbopelvic rhythm) impacts balance, daily activities, and quality of life in 50 adolescents aged 10-18 with idiopathic scoliosis. Researchers will use motion sensors and balance platforms to measure these m…
Sponsor: Hacettepe University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:02 UTC
-
Can a heart scan save lives in rheumatoid arthritis? major study aims to find out
Knowledge-focused By invitation onlyThis study will use advanced heart scans (coronary CT angiography) on 4,000 people with rheumatoid arthritis aged 50-75. The goal is to better understand why people with this condition have higher risks of heart attacks, strokes, and lung problems. Researchers will track particip…
Sponsor: Ellen Margrethe Hauge • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:01 UTC
-
AI tool aims to take guesswork out of scoliosis treatment
Knowledge-focused OngoingThis study tests a computer program designed to help doctors choose the best rehabilitation plan for teens with idiopathic scoliosis. Doctors will first make treatment decisions as usual, then see what the computer suggests for the same patients three months later. The goal is to…
Sponsor: Istituto Scientifico Italiano Colonna Vertebrale • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
Spine surgery alert system put to the test
Knowledge-focused By invitation onlyThis study looks at how well nerve monitoring works during spine surgery to prevent spinal cord damage. Researchers will track nerve signals in 500 adults having neck or upper back surgery. The goal is to make the alert system more accurate so surgeons can act faster to protect n…
Sponsor: Allina Health System • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
Custom 3D knee alignment may improve walking and pain after surgery
Knowledge-focused OngoingThis study looks at whether using a 3D patient-specific alignment during knee replacement surgery leads to better walking, less pain, and stronger muscles. Researchers will measure movement, pain, and strength in 45 adults who had surgery two years ago. The goal is to understand …
Sponsor: KU Leuven • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:14 UTC
-
Rare bone tumor under the microscope: can we predict its behavior?
Knowledge-focused OngoingThis study gathers information from 77 Italian patients with a rare, low-grade bone tumor called clear cell chondrosarcoma. Researchers will review medical records, imaging, and tissue samples to find patterns that might predict whether the tumor will come back or spread. The goa…
Sponsor: Istituto Ortopedico Rizzoli • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC
-
Ankle brace study pulled before it even started
Knowledge-focused CancelledThis study aimed to see if custom carbon fiber braces could reduce forces on the ankle joint after a fracture, potentially lowering the risk of arthritis. It planned to enroll adults with healed ankle fractures and test different brace designs. However, the study was withdrawn be…
Sponsor: University of Iowa • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC
-
Osteoporosis drugs may do more than strengthen bones—study tests muscle benefits
Knowledge-focused OngoingThis study looks at whether common osteoporosis medications also improve muscle health in adults aged 65 and older. Researchers will measure changes in muscle mass, strength, and walking speed over time. The goal is to better understand the link between bone and muscle health in …
Phase 4 • Sponsor: Nami Safai Haeri • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:10 UTC
-
Cleft care network aims to boost outcomes by sharing data
Knowledge-focused By invitation onlyThis study brings together medical teams that treat children with cleft lip and/or palate. They will collect information on speech, hearing, dental health, and quality of life from about 1,000 patients. The goal is to compare results across centers and find ways to improve care. …
Sponsor: Duke University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC
-
120,000-Person study hopes to crack the code of chronic illness
Knowledge-focused PausedThis observational study plans to enroll 120,000 people with various chronic diseases like pancreatitis, diabetes, and arthritis. Researchers will collect blood samples and health data to study how genetics and lifestyle affect disease progression. The goal is to find common dise…
Sponsor: University of Pittsburgh • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC
-
30,000 joint patients enrolled in landmark registry to boost surgery outcomes
Knowledge-focused OngoingThis study is building a large national registry of 30,000 people having hip or knee replacement surgery. Researchers will collect information on pain, physical function, and any complications before and after surgery. The goal is to learn what works best in real-world practice a…
Sponsor: University of Massachusetts, Worcester • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:05 UTC
-
New web tool aims to help sinusitis patients choose surgery or not
Knowledge-focused By invitation onlyThis study is testing a new web-based tool designed to help people with chronic sinusitis make better decisions about their treatment, including whether to have surgery. About 50 patients from USC clinics will use the tool or receive standard information. Researchers will measure…
Sponsor: University of Southern California • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:05 UTC
-
Bone cancer implant infections under the microscope
Knowledge-focused By invitation onlyThis study looks at why people with bone cancer (skeletal sarcoma) get more infections after joint replacement surgery than those with arthritis. Researchers will collect tissue and blood samples from 40 patients to compare immune and bacterial factors. The goal is to understand …
Sponsor: Vastra Gotaland Region • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:01 UTC
-
Promising sarcoma combo study pulled before starting
Knowledge-focused CancelledThis study was designed for adults with certain types of soft tissue sarcoma that have specific immune cell clusters (TLS) in their tumors. Participants would have received pembrolizumab (immunotherapy) with or without olaparib (a DNA repair blocker) before surgery, followed by m…
Phase 2 • Sponsor: Gustave Roussy, Cancer Campus, Grand Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:00 UTC
-
Online fracture care study pulled before it began
Knowledge-focused CancelledThis study aimed to see if a web-based fracture liaison service (e-FLS) could help more older adults start osteoporosis treatment after a fracture compared to standard in-person services. It planned to include men and women over 60 in France who had a low-trauma fracture. However…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:59 UTC
-
Hidden culprit? scientists investigate staphylococcus pettenkoferi in diabetic foot infections
Knowledge-focused OngoingThis study looks at a type of bacteria called Staphylococcus pettenkoferi, often found in diabetic foot ulcers. Researchers will analyze the DNA of 230 bacterial samples to see if certain strains are more harmful. The goal is to understand if this bacteria plays a role in making …
Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:57 UTC
-
Can we predict who will do well after hip surgery?
Knowledge-focused OngoingThis study follows 747 young, active people (ages 14-40) who had hip surgery for femoroacetabular impingement (FAI). Researchers want to find out which patient traits, disease features, and surgical factors lead to the best outcomes. Participants fill out surveys about pain, func…
Sponsor: Washington University School of Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:53 UTC